"path_id"	"full_path_length.x"	"testable_path_length.x"	"drug_targeted_genes"	"proportion_drug_targeted"	"full_path_length.y"	"testable_path_length.y"	"aberrational_genes"	"proportion_aberrational"	"proportion_of_cohort_w_aberrational_gene_in_path"	"Num_patient_with_aberrational_gene_.s._in_path"	"count_of_aberrational_genes_in_path_cross_cohort"	"max_in_one_gene"	"min_in_one_gene"	"hyperg_p_value"	"hyperg_p_w_FDR"
"765"	"Voltage gated Potassium channels"	43	43	2	0.0465116279069767	43	43	41	0.953488372093023	0.32741617357002	166	239	20	0	0.00137278018486819	0.0553738682947877
"338"	"Loss of Nlp from mitotic centrosomes"	62	62	13	0.209677419354839	62	62	58	0.935483870967742	0.388560157790927	197	303	28	0	0.001386010355787	0.0555645430203023
"339"	"Loss of proteins required for interphase microtubule organizationÂ from the centrosome"	62	62	13	0.209677419354839	62	62	58	0.935483870967742	0.388560157790927	197	303	28	0	0.001386010355787	0.0555645430203023
"474"	"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"475"	"Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"476"	"Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"477"	"Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"478"	"Defective CYP19A1 causes Aromatase excess syndrome (AEXS)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"479"	"Defective CYP1B1 causes Glaucoma"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"480"	"Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"481"	"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"482"	"Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"483"	"Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"484"	"Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"485"	"Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"486"	"Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"487"	"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"488"	"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"489"	"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"490"	"Defective FMO3 causes Trimethylaminuria (TMAU)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"491"	"Defective MAOA causes Brunner syndrome (BRUNS)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"492"	"Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"493"	"Phase 1 - Functionalization of compounds"	78	78	11	0.141025641025641	78	78	72	0.923076923076923	0.333333333333333	169	248	8	0	0.00161150912631114	0.060694895270084
"688"	"Amine compound SLC transporters"	30	30	2	0.0666666666666667	30	30	29	0.966666666666667	0.181459566074951	92	110	10	0	0.00189688309756808	0.071033630452419
"805"	"Adherens junctions interactions"	30	30	1	0.0333333333333333	30	30	29	0.966666666666667	0.331360946745562	168	239	27	0	0.00189688309756808	0.071033630452419
"838"	"Elastic fibre formation"	41	41	1	0.024390243902439	41	41	39	0.951219512195122	0.287968441814596	146	195	20	0	0.00199933718498557	0.074656370226675
"287"	"Signaling by PDGF"	184	184	46	0.25	184	184	163	0.885869565217391	0.763313609467456	387	964	85	0	0.002205698838735	0.0821273802936273
"308"	"Semaphorin interactions"	67	67	15	0.223880597014925	67	67	62	0.925373134328358	0.463510848126233	235	399	21	0	0.00244794374385948	0.0908882290705169
"291"	"Signalling by NGF"	287	287	69	0.240418118466899	287	287	250	0.871080139372822	0.824457593688363	418	1305	85	0	0.00250436281155508	0.0927195707868677
"862"	"Amino acid and oligopeptide SLC transporters"	49	49	1	0.0204081632653061	49	49	46	0.938775510204082	0.185404339250493	94	129	7	0	0.00270399306690539	0.099827727193019
"667"	"Degradation of the extracellular matrix"	89	89	7	0.0786516853932584	89	89	81	0.910112359550562	0.469428007889546	238	428	23	0	0.00313959830984101	0.11558317107974
"56"	"CREB phosphorylation through the activation of Ras"	27	27	12	0.444444444444444	27	27	26	0.962962962962963	0.274161735700197	139	191	28	0	0.00355446053628894	0.130123085411138
"512"	"Cell-Cell communication"	130	130	17	0.130769230769231	130	130	116	0.892307692307692	0.694280078895464	352	825	85	0	0.00421237789897111	0.153777632595526
"66"	"Signaling by Leptin"	26	26	11	0.423076923076923	26	26	25	0.961538461538462	0.185404339250493	94	113	28	0	0.00438185644001898	0.156896823954041
"672"	"EGFR downregulation"	26	26	2	0.0769230769230769	26	26	25	0.961538461538462	0.136094674556213	69	82	13	0	0.00438185644001898	0.156896823954041
"674"	"Ligand-gated ion channel transport"	26	26	2	0.0769230769230769	26	26	25	0.961538461538462	0.181459566074951	92	123	12	0	0.00438185644001898	0.156896823954041
"303"	"NCAM signaling for neurite out-growth"	70	70	16	0.228571428571429	70	70	64	0.914285714285714	0.493096646942801	250	469	28	0	0.00516299610070692	0.183359261106625
"45"	"SHC-related events triggered by IGF1R"	25	25	12	0.48	25	25	24	0.96	0.193293885601578	98	111	28	0	0.00540168558878196	0.189773354286686
"431"	"Effects of PIP2 hydrolysis"	25	25	4	0.16	25	25	24	0.96	0.230769230769231	117	149	18	0	0.00540168558878196	0.189773354286686
"432"	"RORA activates circadian gene expression"	25	25	4	0.16	25	25	24	0.96	0.276134122287968	140	180	32	0	0.00540168558878196	0.189773354286686
"269"	"Signaling by EGFR in Cancer"	181	181	47	0.259668508287293	181	181	159	0.878453038674033	0.714003944773176	362	829	85	0	0.00567307555274199	0.197713430483528
"270"	"Signaling by EGFRvIII in Cancer"	181	181	47	0.259668508287293	181	181	159	0.878453038674033	0.714003944773176	362	829	85	0	0.00567307555274199	0.197713430483528
"271"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	181	181	47	0.259668508287293	181	181	159	0.878453038674033	0.714003944773176	362	829	85	0	0.00567307555274199	0.197713430483528
"538"	"Cell surface interactions at the vascular wall"	99	99	12	0.121212121212121	99	99	89	0.898989898989899	0.504930966469428	256	444	85	0	0.0057806978934174	0.200928388025719
"419"	"REV-ERBA represses gene expression"	24	24	4	0.166666666666667	24	24	23	0.958333333333333	0.266272189349112	135	173	32	0	0.00665866509056301	0.229613190753876
"779"	"Cytosolic tRNA aminoacylation"	24	24	1	0.0416666666666667	24	24	23	0.958333333333333	0.122287968441815	62	68	7	0	0.00665866509056301	0.229613190753876
"273"	"Signaling by EGFR"	179	179	46	0.256983240223464	179	179	157	0.877094972067039	0.712031558185404	361	823	85	0	0.0068380123159888	0.234559903780403
"274"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	179	179	46	0.256983240223464	179	179	157	0.877094972067039	0.712031558185404	361	823	85	0	0.0068380123159888	0.234559903780403
"372"	"PI Metabolism"	51	51	10	0.196078431372549	51	51	47	0.92156862745098	0.435897435897436	221	317	85	0	0.00806444430471132	0.275905244516596
"179"	"Endogenous sterols"	23	23	7	0.304347826086957	23	23	22	0.956521739130435	0.130177514792899	66	80	8	0	0.00820789436309188	0.280079844222719
"545"	"Non-integrin membrane-ECM interactions"	42	42	5	0.119047619047619	42	42	39	0.928571428571429	0.406311637080868	206	322	42	0	0.00884387344367787	0.300213806768002
"840"	"tRNA Aminoacylation"	42	42	1	0.0238095238095238	42	42	39	0.928571428571429	0.187376725838264	95	120	7	0	0.00884387344367787	0.300213806768002
"922"	"Diseases of glycosylation"	226	226	1	0.00442477876106195	226	226	196	0.867256637168142	0.652859960552268	331	670	26	0	0.00982908956374495	0.331933587080758
"14"	"SHC1 events in EGFR signaling"	22	22	12	0.545454545454545	22	22	21	0.954545454545455	0.193293885601578	98	108	28	0	0.0101172636009665	0.339037182513814
"39"	"SHC-mediated signalling"	22	22	11	0.5	22	22	21	0.954545454545455	0.177514792899408	90	98	28	0	0.0101172636009665	0.339037182513814
"769"	"Intrinsic Pathway"	22	22	1	0.0454545454545455	22	22	21	0.954545454545455	0.134122287968442	68	80	12	0	0.0101172636009665	0.339037182513814
"581"	"Hemostasis"	497	497	55	0.110663983903421	497	497	422	0.849094567404427	0.95069033530572	482	2378	257	0	0.0105147409451145	0.350846153636923
"49"	"SHC1 events in ERBB2 signaling"	32	32	15	0.46875	32	32	30	0.9375	0.266272189349112	135	173	28	0	0.0105501928485308	0.350846153636923
"610"	"Signal Transduction"	2062	2062	209	0.101357904946654	2062	2062	1708	0.828322017458778	0.990138067061144	502	7623	257	0	0.0109773389137268	0.359492031911012
"63"	"GPVI-mediated activation cascade"	49	49	21	0.428571428571429	49	49	45	0.918367346938776	0.384615384615385	195	259	85	0	0.0109773759477036	0.359492031911012
"340"	"FBXW7 Mutants and NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"343"	"Signaling by NOTCH1"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"344"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"345"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"346"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"347"	"Signaling by NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"348"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	72	72	15	0.208333333333333	72	72	65	0.902777777777778	0.467455621301775	237	399	66	0	0.0110577419310527	0.359492031911012
"516"	"Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell"	140	140	18	0.128571428571429	140	140	123	0.878571428571429	0.631163708086785	320	711	28	0	0.0123100427711218	0.398223668272963
"11"	"GRB2 events in EGFR signaling"	21	21	12	0.571428571428571	21	21	20	0.952380952380952	0.191321499013807	97	106	28	0	0.0124704204734944	0.399456788264012
"21"	"SOS-mediated signalling"	21	21	11	0.523809523809524	21	21	20	0.952380952380952	0.159763313609467	81	91	28	0	0.0124704204734944	0.399456788264012
"46"	"Signal transduction by L1"	21	21	10	0.476190476190476	21	21	20	0.952380952380952	0.167652859960552	85	102	13	0	0.0124704204734944	0.399456788264012
"468"	"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	21	21	3	0.142857142857143	21	21	20	0.952380952380952	0.175542406311637	89	102	43	0	0.0124704204734944	0.399456788264012
"778"	"Sphingolipid metabolism"	71	71	3	0.0422535211267606	71	71	64	0.901408450704225	0.240631163708087	122	166	12	0	0.0125928524657311	0.402392316179207
"217"	"IGF1R signaling cascade"	92	92	26	0.282608695652174	92	92	82	0.891304347826087	0.485207100591716	246	389	85	0	0.0132550714969313	0.421491794753748
"219"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	92	92	26	0.282608695652174	92	92	82	0.891304347826087	0.485207100591716	246	389	85	0	0.0132550714969313	0.421491794753748
"88"	"VEGFA-VEGFR2 Pathway"	105	105	42	0.4	105	105	93	0.885714285714286	0.57396449704142	291	547	85	0	0.0144451048511889	0.454165221116729
"456"	"Circadian Clock"	55	55	8	0.145454545454545	55	55	50	0.909090909090909	0.341222879684418	173	257	32	0	0.0144604835590409	0.454165221116729
"72"	"Activation of NMDA receptor upon glutamate binding and postsynaptic events"	39	39	16	0.41025641025641	39	39	36	0.923076923076923	0.382642998027613	194	293	28	0	0.0144972891407766	0.454165221116729
"833"	"Formation of Fibrin Clot (Clotting Cascade)"	39	39	1	0.0256410256410256	39	39	36	0.923076923076923	0.214990138067061	109	156	15	0	0.0144972891407766	0.454165221116729
"834"	"Glycosphingolipid metabolism"	39	39	1	0.0256410256410256	39	39	36	0.923076923076923	0.140039447731755	71	90	6	0	0.0144972891407766	0.454165221116729
"232"	"Signaling by FGFR in disease"	177	177	49	0.27683615819209	177	177	154	0.870056497175141	0.70414201183432	357	841	85	0	0.0145258409274627	0.454165221116729
"42"	"Interleukin-2 signaling"	47	47	23	0.48936170212766	47	47	43	0.914893617021277	0.386587771203156	196	257	85	0	0.0148787338525163	0.462983545805136
"189"	"NOTCH1 Intracellular Domain Regulates Transcription"	47	47	14	0.297872340425532	47	47	43	0.914893617021277	0.422090729783037	214	324	66	0	0.0148787338525163	0.462983545805136
"50"	"GRB2 events in ERBB2 signaling"	30	30	14	0.466666666666667	30	30	28	0.933333333333333	0.260355029585799	132	159	28	0	0.0151498386349074	0.465873437131783
"367"	"Signaling by FGFR1 mutants"	30	30	6	0.2	30	30	28	0.933333333333333	0.305719921104536	155	183	85	0	0.0151498386349074	0.465873437131783
"409"	"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity"	30	30	5	0.166666666666667	30	30	28	0.933333333333333	0.218934911242604	111	148	15	0	0.0151498386349074	0.465873437131783
"426"	"Trafficking of AMPA receptors"	30	30	5	0.166666666666667	30	30	28	0.933333333333333	0.218934911242604	111	148	15	0	0.0151498386349074	0.465873437131783
"810"	"Molecules associated with elastic fibres"	30	30	1	0.0333333333333333	30	30	28	0.933333333333333	0.207100591715976	105	129	20	0	0.0151498386349074	0.465873437131783
"451"	"Syndecan interactions"	20	20	3	0.15	20	20	19	0.95	0.11439842209073	58	70	10	0	0.0153704243277355	0.470442830069417
"196"	"Signaling by ERBB2"	163	163	48	0.294478527607362	163	163	142	0.871165644171779	0.694280078895464	352	784	85	0	0.0161607024207289	0.493475205015802
"737"	"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds"	97	97	5	0.0515463917525773	97	97	86	0.88659793814433	0.382642998027613	194	301	12	0	0.016424046912628	0.500347525715634
"542"	"p75 NTR receptor-mediated signalling"	83	83	10	0.120481927710843	83	83	74	0.891566265060241	0.449704142011834	228	390	32	0	0.0167462430852645	0.508976589462501
"378"	"Signaling by Hedgehog"	136	136	26	0.191176470588235	136	136	119	0.875	0.538461538461538	273	499	25	0	0.0180169181682448	0.546326299780136
"799"	"Interaction between L1 and Ankyrins"	29	29	1	0.0344827586206897	29	29	27	0.931034482758621	0.384615384615385	195	331	28	0	0.0181308761176726	0.548509199037669
"307"	"Signaling by Insulin receptor"	116	116	26	0.224137931034483	116	116	102	0.879310344827586	0.502958579881657	255	419	85	0	0.0185727504234307	0.560579482452969
"199"	"IRS-related events triggered by IGF1R"	89	89	26	0.292134831460674	89	89	79	0.887640449438202	0.473372781065089	240	377	85	0	0.0186462394304396	0.56150082520738
"336"	"Signaling by FGFR1 fusion mutants"	19	19	4	0.210526315789474	19	19	18	0.947368421052632	0.282051282051282	143	166	85	0	0.0189442470826947	0.567857978354561
"208"	"Downstream signal transduction"	161	161	46	0.285714285714286	161	161	140	0.869565217391304	0.719921104536489	365	793	85	0	0.0192262861121941	0.574993368247646
"508"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	37	37	5	0.135135135135135	37	37	34	0.918918918918919	0.29585798816568	150	204	32	0	0.0200476866171442	0.596827212149887
"238"	"Signaling by ERBB4"	154	154	42	0.272727272727273	154	154	134	0.87012987012987	0.629191321499014	319	648	85	0	0.0202995263159824	0.602951110280385
"644"	"Assembly of the primary cilium"	179	179	16	0.0893854748603352	179	179	155	0.865921787709497	0.619329388560158	314	710	28	0	0.0208315811298694	0.617351512877761
"64"	"SHC1 events in ERBB4 signaling"	28	28	12	0.428571428571429	28	28	26	0.928571428571429	0.218934911242604	111	133	28	0	0.0216782827236894	0.640990330947096
"396"	"Apoptotic execution  phase"	52	52	9	0.173076923076923	52	52	47	0.903846153846154	0.374753451676529	190	293	42	0	0.0220175381248489	0.649551967532707
"392"	"G2/M Transition"	114	114	20	0.175438596491228	114	114	100	0.87719298245614	0.514792899408284	261	481	32	0	0.0226432874058669	0.666508021688234
"36"	"Regulation of signaling by CBL"	18	18	9	0.5	18	18	17	0.944444444444444	0.2465483234714	125	143	85	0	0.0233483168270285	0.681124395835137
"314"	"Tie2 Signaling"	18	18	4	0.222222222222222	18	18	17	0.944444444444444	0.272189349112426	138	162	85	0	0.0233483168270285	0.681124395835137
"580"	"cGMP effects"	18	18	2	0.111111111111111	18	18	17	0.944444444444444	0.153846153846154	78	98	19	0	0.0233483168270285	0.681124395835137
"654"	"ABC-family proteins mediated transport"	36	36	3	0.0833333333333333	36	36	33	0.916666666666667	0.333333333333333	169	251	19	0	0.0235338782960772	0.681970883695733
"393"	"Regulation of PLK1 Activity at G2/M Transition"	80	80	14	0.175	80	80	71	0.8875	0.42603550295858	216	353	28	0	0.0236879966713655	0.684918300450443
"96"	"Signaling by VEGF"	113	113	44	0.389380530973451	113	113	99	0.876106194690266	0.591715976331361	300	584	85	0	0.0249669071912968	0.720303320264419
"59"	"Prolonged ERK activation events"	27	27	12	0.444444444444444	27	27	25	0.925925925925926	0.203155818540434	103	120	28	0	0.0258941499370011	0.743770816001988
"192"	"Integrin alphaIIb beta3 signaling"	27	27	8	0.296296296296296	27	27	25	0.925925925925926	0.222879684418146	113	139	19	0	0.0258941499370011	0.743770816001988
"53"	"Post NMDA receptor activation events"	35	35	16	0.457142857142857	35	35	32	0.914285714285714	0.345167652859961	175	248	28	0	0.0275920812480899	0.787350040202843
"353"	"Bile acid and bile salt metabolism"	35	35	7	0.2	35	35	32	0.914285714285714	0.195266272189349	99	132	10	0	0.0275920812480899	0.787350040202843
"218"	"Insulin receptor signalling cascade"	92	92	26	0.282608695652174	92	92	81	0.880434782608696	0.479289940828402	243	372	85	0	0.0280844080123694	0.799652796080262
"205"	"NGF signalling via TRKA from the plasma membrane"	206	206	59	0.286407766990291	206	206	177	0.859223300970874	0.733727810650888	372	920	85	0	0.0283379549037329	0.805118016139488
"9"	"RAF/MAP kinase cascade"	17	17	10	0.588235294117647	17	17	16	0.941176470588235	0.145956607495069	74	79	28	0	0.0287753454711872	0.814005693695316
"198"	"IRS-mediated signalling"	85	85	25	0.294117647058824	85	85	75	0.882352941176471	0.467455621301775	237	354	85	0	0.0289636615958049	0.817563219942694
"202"	"Signaling by FGFR"	162	162	47	0.290123456790123	162	162	140	0.864197530864197	0.684418145956608	347	774	85	0	0.0299204584029995	0.842750723830548
"195"	"Downstream signaling of activated FGFR"	149	149	44	0.295302013422819	149	149	129	0.865771812080537	0.684418145956608	347	745	85	0	0.0310826973509043	0.87172932293746
"758"	"Neurotransmitter Release Cycle"	42	42	2	0.0476190476190476	42	42	38	0.904761904761905	0.264299802761341	134	174	20	0	0.0311653337960992	0.872175281347859
"398"	"Mitotic G2-G2/M phases"	116	116	20	0.172413793103448	116	116	101	0.870689655172414	0.516765285996055	262	483	32	0	0.0346799857460773	0.968460537742473
"381"	"Polo-like kinase mediated events"	16	16	3	0.1875	16	16	15	0.9375	0.118343195266272	60	65	32	0	0.0354627376214744	0.979850886591015
"531"	"STING mediated induction of host immune responses"	16	16	2	0.125	16	16	15	0.9375	0.122287968441815	62	70	23	0	0.0354627376214744	0.979850886591015
"704"	"Cell-extracellular matrix interactions"	16	16	1	0.0625	16	16	15	0.9375	0.108481262327416	55	64	18	0	0.0354627376214744	0.979850886591015
"709"	"TRAF6 mediated induction of TAK1 complex"	16	16	1	0.0625	16	16	15	0.9375	0.0927021696252465	47	56	16	0	0.0354627376214744	0.979850886591015
"121"	"EPHB-mediated forward signaling"	41	41	15	0.365853658536585	41	41	37	0.902439024390244	0.331360946745562	168	226	28	0	0.0359894188665795	0.992305421496917
"43"	"Frs2-mediated activation"	25	25	12	0.48	25	25	23	0.92	0.185404339250493	94	108	28	0	0.0368261731333082	1
"44"	"SHC-related events"	25	25	12	0.48	25	25	23	0.92	0.183431952662722	93	102	28	0	0.0368261731333082	1
"666"	"Nitric oxide stimulates guanylate cyclase"	25	25	2	0.08	25	25	23	0.92	0.193293885601578	98	132	19	0	0.0368261731333082	1
"239"	"Synthesis of PIPs at the plasma membrane"	33	33	9	0.272727272727273	33	33	30	0.909090909090909	0.370808678500986	188	240	85	0	0.0377785159701638	1
"643"	"deactivation of the beta-catenin transactivating complex"	33	33	3	0.0909090909090909	33	33	30	0.909090909090909	0.26232741617357	133	168	53	0	0.0377785159701638	1
"520"	"Activation of gene expression by SREBF (SREBP)"	40	40	5	0.125	40	40	36	0.9	0.287968441814596	146	190	29	0	0.0415002460120255	1
"194"	"IRS-related events"	88	88	26	0.295454545454545	88	88	77	0.875	0.467455621301775	237	358	85	0	0.0423172860551271	1
"813"	"Cell death signalling via NRAGE, NRIF and NADE"	61	61	2	0.0327868852459016	61	61	54	0.885245901639344	0.378698224852071	192	291	32	0	0.0433750835751494	1
"473"	"Signaling by WNT in cancer"	212	212	30	0.141509433962264	212	212	181	0.85377358490566	0.666666666666667	338	738	53	0	0.0435809305056202	1
"262"	"CREB phosphorylation through the activation of CaMKII"	15	15	4	0.266666666666667	15	15	14	0.933333333333333	0.159763313609467	81	101	28	0	0.0437029465574676	1
"509"	"Depolymerisation of the Nuclear Lamina"	15	15	2	0.133333333333333	15	15	14	0.933333333333333	0.0788954635108481	40	42	8	0	0.0437029465574676	1
"696"	"Regulation of innate immune responses to cytosolic DNA"	15	15	1	0.0666666666666667	15	15	14	0.933333333333333	0.0690335305719921	35	43	10	0	0.0437029465574676	1
"423"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	24	24	4	0.166666666666667	24	24	22	0.916666666666667	0.124260355029586	63	77	8	0	0.0438401676312569	1
"48"	"CD28 co-stimulation"	32	32	15	0.46875	32	32	29	0.90625	0.307692307692308	156	191	85	0	0.0441119166768016	1
"143"	"Signaling by SCF-KIT"	144	144	49	0.340277777777778	144	144	124	0.861111111111111	0.627218934911243	318	619	85	0	0.0466325196955575	1
"919"	"Processing of Capped Intron-Containing Pre-mRNA"	144	144	1	0.00694444444444444	144	144	124	0.861111111111111	0.435897435897436	221	396	11	0	0.0466325196955575	1
"865"	"Potassium Channels"	99	99	2	0.0202020202020202	99	99	86	0.868686868686869	0.485207100591716	246	435	21	0	0.050951127580234	1
"22"	"ARMS-mediated activation"	23	23	12	0.521739130434783	23	23	21	0.91304347826087	0.179487179487179	91	104	28	0	0.0521233868342079	1
"127"	"Activation of Rac"	14	14	5	0.357142857142857	14	14	13	0.928571428571429	0.16370808678501	83	94	23	0	0.0538562277832439	1
"213"	"Signal attenuation"	14	14	4	0.285714285714286	14	14	13	0.928571428571429	0.0729783037475345	37	41	8	0	0.0538562277832439	1
"327"	"DCC mediated attractive signaling"	14	14	3	0.214285714285714	14	14	13	0.928571428571429	0.159763313609467	81	95	23	0	0.0538562277832439	1
"330"	"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"	14	14	3	0.214285714285714	14	14	13	0.928571428571429	0.189349112426035	96	114	19	0	0.0538562277832439	1
"459"	"FGFR1 ligand binding and activation"	14	14	2	0.142857142857143	14	14	13	0.928571428571429	0.0394477317554241	20	21	4	0	0.0538562277832439	1
"67"	"Interleukin-3, 5 and GM-CSF signaling"	45	45	19	0.422222222222222	45	45	40	0.888888888888889	0.3767258382643	191	246	85	0	0.0560776429313871	1
"366"	"Signaling by FGFR mutants"	45	45	9	0.2	45	45	40	0.888888888888889	0.370808678500986	188	242	85	0	0.0560776429313871	1
"794"	"Cell junction organization"	85	85	3	0.0352941176470588	85	85	74	0.870588235294118	0.493096646942801	250	469	34	0	0.0568642861230059	1
"804"	"Activated NOTCH1 Transmits Signal to the Nucleus"	30	30	1	0.0333333333333333	30	30	27	0.9	0.242603550295858	123	150	66	0	0.0598654008763844	1
"15"	"Signalling to p38 via RIT and RIN"	22	22	12	0.545454545454545	22	22	20	0.909090909090909	0.16370808678501	83	94	28	0	0.0618867147965826	1
"768"	"Common Pathway"	22	22	1	0.0454545454545455	22	22	20	0.909090909090909	0.145956607495069	74	97	15	0	0.0618867147965826	1
"135"	"Nuclear Receptor transcription pathway"	51	51	18	0.352941176470588	51	51	45	0.882352941176471	0.199211045364892	101	142	11	0	0.0629268102302352	1
"289"	"Platelet Aggregation (Plug Formation)"	37	37	9	0.243243243243243	37	37	33	0.891891891891892	0.248520710059172	126	160	19	0	0.0630440506573184	1
"123"	"FRS2-mediated cascade"	44	44	16	0.363636363636364	44	44	39	0.886363636363636	0.242603550295858	123	141	28	0	0.0637094892098882	1
"221"	"DAP12 signaling"	164	164	46	0.280487804878049	164	164	140	0.853658536585366	0.70414201183432	357	787	85	0	0.0648580593097794	1
"299"	"NF-kB is activated and signals survival"	13	13	3	0.230769230769231	13	13	12	0.923076923076923	0.0611439842209073	31	33	9	0	0.0663663447513348	1
"443"	"IRF3-mediated induction of type I IFN"	13	13	2	0.153846153846154	13	13	12	0.923076923076923	0.108481262327416	55	63	23	0	0.0663663447513348	1
"676"	"Retrograde neurotrophin signalling"	13	13	1	0.0769230769230769	13	13	12	0.923076923076923	0.0729783037475345	37	39	10	0	0.0663663447513348	1
"304"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	50	0.87719298245614	0.439842209072978	223	343	66	0	0.0685798999216276	1
"305"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	50	0.87719298245614	0.439842209072978	223	343	66	0	0.0685798999216276	1
"503"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	29	29	4	0.137931034482759	29	29	26	0.896551724137931	0.211045364891519	107	139	29	0	0.0695682719049175	1
"800"	"PIWI-interacting RNA (piRNA) biogenesis"	29	29	1	0.0344827586206897	29	29	26	0.896551724137931	0.165680473372781	84	104	12	0	0.0695682719049175	1
"831"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	36	36	1	0.0277777777777778	36	36	32	0.888888888888889	0.138067061143984	70	87	10	0	0.0722323137202296	1
"517"	"Signaling by Wnt"	286	286	36	0.125874125874126	286	286	241	0.842657342657343	0.747534516765286	379	1026	53	0	0.072860186162954	1
"62"	"ERK/MAPK targets"	21	21	9	0.428571428571429	21	21	19	0.904761904761905	0.120315581854043	61	65	10	0	0.0733705014125552	1
"102"	"CD28 dependent PI3K/Akt signaling"	21	21	8	0.380952380952381	21	21	19	0.904761904761905	0.26232741617357	133	152	85	0	0.0733705014125552	1
"32"	"MAP kinase activation in TLR cascade"	56	56	28	0.5	56	56	49	0.875	0.266272189349112	135	173	10	0	0.0766161545211379	1
"176"	"EPH-Ephrin signaling"	94	94	29	0.308510638297872	94	94	81	0.861702127659574	0.542406311637081	275	488	28	0	0.0796285304086178	1
"93"	"Interleukin receptor SHC signaling"	28	28	11	0.392857142857143	28	28	25	0.892857142857143	0.323471400394477	164	199	85	0	0.0807004237100531	1
"328"	"PKB-mediated events"	28	28	6	0.214285714285714	28	28	25	0.892857142857143	0.149901380670611	76	89	15	0	0.0807004237100531	1
"2"	"ERK activation"	12	12	9	0.75	12	12	11	0.916666666666667	0.0867850098619329	44	47	8	0	0.0817799095358921	1
"10"	"Serotonin receptors"	12	12	7	0.583333333333333	12	12	11	0.916666666666667	0.0986193293885602	50	55	9	0	0.0817799095358921	1
"279"	"ERKs are inactivated"	12	12	3	0.25	12	12	11	0.916666666666667	0.0631163708086785	32	34	8	0	0.0817799095358921	1
"281"	"NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"	12	12	3	0.25	12	12	11	0.916666666666667	0.14792899408284	75	81	42	0	0.0817799095358921	1
"657"	"Miscellaneous substrates"	12	12	1	0.0833333333333333	12	12	11	0.916666666666667	0.0670611439842209	34	37	8	0	0.0817799095358921	1
"368"	"Signaling by Hippo"	20	20	4	0.2	20	20	18	0.9	0.108481262327416	55	67	10	0	0.08684687942692	1
"744"	"Fatty Acyl-CoA Biosynthesis"	20	20	1	0.05	20	20	18	0.9	0.116370808678501	59	64	17	0	0.08684687942692	1
"290"	"Hedgehog 'off' state"	99	99	24	0.242424242424242	99	99	85	0.858585858585859	0.451676528599605	229	356	25	0	0.0881575420528988	1
"313"	"Sema4D in semaphorin signaling"	27	27	6	0.222222222222222	27	27	24	0.888888888888889	0.22879684418146	116	153	17	0	0.0934382189435308	1
"315"	"mTOR signalling"	27	27	6	0.222222222222222	27	27	24	0.888888888888889	0.14792899408284	75	87	15	0	0.0934382189435308	1
"453"	"Synthesis of bile acids and bile salts"	27	27	4	0.148148148148148	27	27	24	0.888888888888889	0.140039447731755	71	87	8	0	0.0934382189435308	1
"296"	"PLCG1 events in ERBB2 signaling"	34	34	8	0.235294117647059	34	34	30	0.882352941176471	0.345167652859961	175	242	25	0	0.0943064929273419	1
"616"	"HDACs deacetylate histones"	60	60	6	0.1	60	60	52	0.866666666666667	0.26232741617357	133	184	16	0	0.099789259790378	1
"55"	"Purine ribonucleoside monophosphate biosynthesis"	11	11	5	0.454545454545455	11	11	10	0.909090909090909	0.0631163708086785	32	35	8	0	0.100770199007681	1
"124"	"Interleukin-6 signaling"	11	11	4	0.363636363636364	11	11	10	0.909090909090909	0.0749506903353057	38	41	7	0	0.100770199007681	1
"125"	"Interleukin-7 signaling"	11	11	4	0.363636363636364	11	11	10	0.909090909090909	0.0808678500986193	41	46	10	0	0.100770199007681	1
"126"	"Transport of organic anions"	11	11	4	0.363636363636364	11	11	10	0.909090909090909	0.100591715976331	51	66	10	0	0.100770199007681	1
"385"	"FGFR1c ligand binding and activation"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.0315581854043393	16	17	4	0	0.100770199007681	1
"387"	"Signaling by activated point mutants of FGFR1"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.0315581854043393	16	17	4	0	0.100770199007681	1
"388"	"mTORC1-mediated signalling"	11	11	2	0.181818181818182	11	11	10	0.909090909090909	0.0848126232741617	43	45	15	0	0.100770199007681	1
"637"	"Dimerization of procaspase-8"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.108481262327416	55	58	42	0	0.100770199007681	1
"638"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.0611439842209073	31	34	10	0	0.100770199007681	1
"642"	"Regulation by c-FLIP"	11	11	1	0.0909090909090909	11	11	10	0.909090909090909	0.108481262327416	55	58	42	0	0.100770199007681	1
"241"	"Hedgehog 'on' state"	85	85	23	0.270588235294118	85	85	73	0.858823529411765	0.339250493096647	172	238	13	0	0.101182234663561	1
"20"	"Ephrin signaling"	19	19	10	0.526315789473684	19	19	17	0.894736842105263	0.138067061143984	70	78	12	0	0.102621572225036	1
"732"	"Glucuronidation"	19	19	1	0.0526315789473684	19	19	17	0.894736842105263	0.120315581854043	61	70	12	0	0.102621572225036	1
"631"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	53	53	5	0.0943396226415094	53	53	46	0.867924528301887	0.333333333333333	169	242	29	0	0.105807735785343	1
"333"	"EGFR interacts with phospholipase C-gamma"	33	33	7	0.212121212121212	33	33	29	0.878787878787879	0.333333333333333	169	234	25	0	0.107445923743179	1
"334"	"PLC-gamma1 signalling"	33	33	7	0.212121212121212	33	33	29	0.878787878787879	0.317554240631164	161	218	25	0	0.107445923743179	1
"100"	"VEGFR2 mediated vascular permeability"	26	26	10	0.384615384615385	26	26	23	0.884615384615385	0.167652859960552	85	102	12	0	0.107971279038743	1
"671"	"Downregulation of TGF-beta receptor signaling"	26	26	2	0.0769230769230769	26	26	23	0.884615384615385	0.157790927021696	80	92	20	0	0.107971279038743	1
"444"	"Nuclear signaling by ERBB4"	39	39	6	0.153846153846154	39	39	34	0.871794871794872	0.218934911242604	111	146	19	0	0.117472132478797	1
"435"	"RNF mutants show enhanced WNT signaling and proliferation"	190	190	30	0.157894736842105	190	190	160	0.842105263157895	0.652859960552268	331	695	53	0	0.11822180488946	1
"437"	"TCF dependent signaling in response to WNT"	190	190	30	0.157894736842105	190	190	160	0.842105263157895	0.652859960552268	331	695	53	0	0.11822180488946	1
"438"	"XAV939 inhibits tankyrase, stabilizing AXIN"	190	190	30	0.157894736842105	190	190	160	0.842105263157895	0.652859960552268	331	695	53	0	0.11822180488946	1
"439"	"misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling"	190	190	30	0.157894736842105	190	190	160	0.842105263157895	0.652859960552268	331	695	53	0	0.11822180488946	1
"789"	"Peptide hormone metabolism"	83	83	3	0.036144578313253	83	83	71	0.855421686746988	0.319526627218935	162	245	14	0	0.119782848618625	1
"403"	"Activation of SMO"	18	18	3	0.166666666666667	18	18	16	0.888888888888889	0.124260355029586	63	70	13	0	0.121034832421886	1
"576"	"Norepinephrine Neurotransmitter Release Cycle"	18	18	2	0.111111111111111	18	18	16	0.888888888888889	0.159763313609467	81	96	20	0	0.121034832421886	1
"579"	"Synthesis of PIPs at the Golgi membrane"	18	18	2	0.111111111111111	18	18	16	0.888888888888889	0.136094674556213	69	74	16	0	0.121034832421886	1
"899"	"mRNA Splicing"	113	113	1	0.00884955752212389	113	113	96	0.849557522123894	0.353057199211045	179	281	10	0	0.1219150672484	1
"900"	"mRNA Splicing - Major Pathway"	113	113	1	0.00884955752212389	113	113	96	0.849557522123894	0.353057199211045	179	281	10	0	0.1219150672484	1
"17"	"VEGFR2 mediated cell proliferation"	32	32	17	0.53125	32	32	28	0.875	0.26232741617357	133	171	28	0	0.122164968849588	1
"321"	"Signaling by Robo receptor"	32	32	7	0.21875	32	32	28	0.875	0.244575936883629	124	167	23	0	0.122164968849588	1
"380"	"Activation of Matrix Metalloproteinases"	32	32	6	0.1875	32	32	28	0.875	0.149901380670611	76	87	10	0	0.122164968849588	1
"706"	"Sphingolipid de novo biosynthesis"	32	32	2	0.0625	32	32	28	0.875	0.140039447731755	71	76	12	0	0.122164968849588	1
"707"	"TGF-beta receptor signaling activates SMADs"	32	32	2	0.0625	32	32	28	0.875	0.185404339250493	94	109	20	0	0.122164968849588	1
"5"	"ERK1 activation"	10	10	7	0.7	10	10	9	0.9	0.0650887573964497	33	34	7	0	0.124166481267184	1
"78"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	10	10	4	0.4	10	10	9	0.9	0.0414201183431953	21	21	4	0	0.124166481267184	1
"187"	"Regulation of signaling by NODAL"	10	10	3	0.3	10	10	9	0.9	0.0414201183431953	21	21	8	0	0.124166481267184	1
"360"	"Regulation of Rheb GTPase activity by AMPK"	10	10	2	0.2	10	10	9	0.9	0.0453648915187377	23	24	6	0	0.124166481267184	1
"611"	"Acetylcholine regulates insulin secretion"	10	10	1	0.1	10	10	9	0.9	0.0966469428007889	49	54	20	0	0.124166481267184	1
"622"	"TRIF-mediated programmed cell death"	10	10	1	0.1	10	10	9	0.9	0.136094674556213	69	73	42	0	0.124166481267184	1
"584"	"Collagen degradation"	38	38	4	0.105263157894737	38	38	33	0.868421052631579	0.256410256410256	130	175	23	0	0.132008655897158	1
"588"	"Transport of vitamins, nucleosides, and related molecules"	38	38	4	0.105263157894737	38	38	33	0.868421052631579	0.16370808678501	83	107	10	0	0.132008655897158	1
"97"	"NOD1/2 Signaling Pathway"	31	31	12	0.387096774193548	31	31	27	0.870967741935484	0.218934911242604	111	138	42	0	0.138601499421303	1
"373"	"DAG and IP3 signaling"	31	31	6	0.193548387096774	31	31	27	0.870967741935484	0.309664694280079	157	214	25	0	0.138601499421303	1
"506"	"G-protein mediated events"	44	44	6	0.136363636363636	44	44	38	0.863636363636364	0.368836291913215	187	273	25	0	0.138956815675109	1
"507"	"G2/M Checkpoints"	44	44	6	0.136363636363636	44	44	38	0.863636363636364	0.224852071005917	114	129	20	0	0.138956815675109	1
"71"	"TRAF6 Mediated Induction of proinflammatory cytokines"	75	75	31	0.413333333333333	75	75	64	0.853333333333333	0.305719921104536	155	224	10	0	0.140204834093392	1
"780"	"G alpha (12/13) signalling events"	75	75	3	0.04	75	75	64	0.853333333333333	0.514792899408284	261	428	85	0	0.140204834093392	1
"47"	"activated TAK1 mediates p38 MAPK activation"	17	17	8	0.470588235294118	17	17	15	0.882352941176471	0.0946745562130177	48	52	7	0	0.142461012026071	1
"389"	"Energy dependent regulation of mTOR by LKB1-AMPK"	17	17	3	0.176470588235294	17	17	15	0.882352941176471	0.0808678500986193	41	45	6	0	0.142461012026071	1
"553"	"PKA activation in glucagon signalling"	17	17	2	0.117647058823529	17	17	15	0.882352941176471	0.205128205128205	104	121	25	0	0.142461012026071	1
"662"	"Metabolism of lipids and lipoproteins"	569	569	46	0.0808435852372583	569	569	471	0.827768014059754	0.889546351084813	451	1899	85	0	0.142518172281326	1
"342"	"Sema4D induced cell migration and growth-cone collapse"	24	24	5	0.208333333333333	24	24	21	0.875	0.209072978303748	106	137	17	0	0.143238798066669	1
"729"	"Activation of ATR in response to replication stress"	37	37	2	0.0540540540540541	37	37	32	0.864864864864865	0.195266272189349	99	107	20	0	0.148035483989247	1
"316"	"PI3K Cascade"	68	68	15	0.220588235294118	68	68	58	0.852941176470588	0.382642998027613	194	269	85	0	0.151339112258078	1
"680"	"Biological oxidations"	174	174	13	0.0747126436781609	174	174	146	0.839080459770115	0.495069033530572	251	460	12	0	0.151372246173995	1
"167"	"Constitutive PI3K/AKT Signaling in Cancer"	86	86	28	0.325581395348837	86	86	73	0.848837209302326	0.469428007889546	238	379	85	0	0.152791560505084	1
"6"	"ERK2 activation"	9	9	6	0.666666666666667	9	9	8	0.888888888888889	0.0769230769230769	39	40	8	0	0.152990126126492	1
"13"	"Metabolism of folate and pterines"	9	9	5	0.555555555555556	9	9	8	0.888888888888889	0.0355029585798817	18	19	5	0	0.152990126126492	1
"57"	"EGFR Transactivation by Gastrin"	9	9	4	0.444444444444444	9	9	8	0.888888888888889	0.108481262327416	55	59	28	0	0.152990126126492	1
"146"	"AKT phosphorylates targets in the nucleus"	9	9	3	0.333333333333333	9	9	8	0.888888888888889	0.0453648915187377	23	23	7	0	0.152990126126492	1
"158"	"Regulation of gene expression by Hypoxia-inducible Factor"	9	9	3	0.333333333333333	9	9	8	0.888888888888889	0.161735700197239	82	86	32	0	0.152990126126492	1
"311"	"Role of Abl in Robo-Slit signaling"	9	9	2	0.222222222222222	9	9	8	0.888888888888889	0.108481262327416	55	61	23	0	0.152990126126492	1
"312"	"S6K1-mediated signalling"	9	9	2	0.222222222222222	9	9	8	0.888888888888889	0.0828402366863905	42	43	15	0	0.152990126126492	1
"497"	"PLC beta mediated events"	43	43	6	0.13953488372093	43	43	37	0.86046511627907	0.366863905325444	186	269	25	0	0.154458307113891	1
"51"	"MAPK targets/ Nuclear events mediated by MAP kinases"	30	30	14	0.466666666666667	30	30	26	0.866666666666667	0.149901380670611	76	85	10	0	0.156894111161716	1
"104"	"Signaling by Interleukins"	109	109	41	0.376146788990826	109	109	92	0.844036697247706	0.516765285996055	262	428	85	0	0.160967515208608	1
"319"	"PCP/CE pathway"	91	91	20	0.21978021978022	91	91	77	0.846153846153846	0.317554240631164	161	237	12	0	0.164141559307597	1
"513"	"Double-Strand Break Repair"	23	23	3	0.130434782608696	23	23	20	0.869565217391304	0.222879684418146	113	148	23	0	0.164401658401517	1
"514"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	23	23	3	0.130434782608696	23	23	20	0.869565217391304	0.171597633136095	87	111	18	0	0.164401658401517	1
"216"	"Assembly of the pre-replicative complex"	67	67	19	0.283582089552239	67	67	57	0.850746268656716	0.21301775147929	108	132	8	0	0.164691636233102	1
"31"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	16	16	8	0.5	16	16	14	0.875	0.0907297830374754	46	52	7	0	0.167306080597364	1
"175"	"p75NTR signals via NF-kB"	16	16	5	0.3125	16	16	14	0.875	0.0729783037475345	37	41	9	0	0.167306080597364	1
"282"	"Nucleotide-like (purinergic) receptors"	16	16	4	0.25	16	16	14	0.875	0.0611439842209073	31	33	7	0	0.167306080597364	1
"285"	"Rap1 signalling"	16	16	4	0.25	16	16	14	0.875	0.0907297830374754	46	47	6	0	0.167306080597364	1
"383"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	16	16	3	0.1875	16	16	14	0.875	0.118343195266272	60	68	20	0	0.167306080597364	1
"525"	"Metabolism of Angiotensinogen to Angiotensins"	16	16	2	0.125	16	16	14	0.875	0.120315581854043	61	71	14	0	0.167306080597364	1
"527"	"PKA activation"	16	16	2	0.125	16	16	14	0.875	0.193293885601578	98	114	25	0	0.167306080597364	1
"710"	"Trafficking of GluR2-containing AMPA receptors"	16	16	1	0.0625	16	16	14	0.875	0.169625246548323	86	99	15	0	0.167306080597364	1
"587"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	114	114	12	0.105263157894737	114	114	96	0.842105263157895	0.50887573964497	258	455	32	0	0.170381752340864	1
"628"	"Netrin-1 signaling"	42	42	4	0.0952380952380952	42	42	36	0.857142857142857	0.353057199211045	179	272	23	0	0.171338455634719	1
"105"	"EPH-ephrin mediated repulsion of cells"	48	48	18	0.375	48	48	41	0.854166666666667	0.335305719921105	170	240	24	0	0.174992121729833	1
"349"	"SHC-mediated cascade"	29	29	6	0.206896551724138	29	29	25	0.862068965517241	0.16370808678501	83	89	28	0	0.177179072687894	1
"397"	"CDO in myogenesis"	29	29	5	0.172413793103448	29	29	25	0.862068965517241	0.201183431952663	102	126	26	0	0.177179072687894	1
"399"	"Myogenesis"	29	29	5	0.172413793103448	29	29	25	0.862068965517241	0.201183431952663	102	126	26	0	0.177179072687894	1
"350"	"Phospholipase C-mediated cascade"	54	54	11	0.203703703703704	54	54	46	0.851851851851852	0.372781065088757	189	264	25	0	0.177232137831357	1
"698"	"Translocation of GLUT4 to the plasma membrane"	60	60	4	0.0666666666666667	60	60	51	0.85	0.414201183431953	210	342	26	0	0.178457550136657	1
"806"	"Cell-cell junction organization"	60	60	2	0.0333333333333333	60	60	51	0.85	0.390532544378698	198	295	27	0	0.178457550136657	1
"54"	"CTLA4 inhibitory signaling"	22	22	10	0.454545454545455	22	22	19	0.863636363636364	0.0966469428007889	49	56	7	0	0.188208367572282	1
"770"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	22	22	1	0.0454545454545455	22	22	19	0.863636363636364	0.102564102564103	52	55	10	0	0.188208367572282	1
"772"	"Smooth Muscle Contraction"	22	22	1	0.0454545454545455	22	22	19	0.863636363636364	0.118343195266272	60	72	19	0	0.188208367572282	1
"34"	"Neurotransmitter Clearance In The Synaptic Cleft"	8	8	4	0.5	8	8	7	0.875	0.0394477317554241	20	21	6	0	0.188499067635728	1
"521"	"ChREBP activates metabolic gene expression"	8	8	1	0.125	8	8	7	0.875	0.0788954635108481	40	47	17	0	0.188499067635728	1
"524"	"Ligand-receptor interactions"	8	8	1	0.125	8	8	7	0.875	0.0769230769230769	39	41	13	0	0.188499067635728	1
"529"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	8	8	1	0.125	8	8	7	0.875	0.0256410256410256	13	13	4	0	0.188499067635728	1
"530"	"Release of Hh-Np from the secreting cell"	8	8	1	0.125	8	8	7	0.875	0.0532544378698225	27	28	10	0	0.188499067635728	1
"532"	"Sema4D mediated inhibition of cell attachment and migration"	8	8	1	0.125	8	8	7	0.875	0.0867850098619329	44	49	12	0	0.188499067635728	1
"533"	"Synthesis of PG"	8	8	1	0.125	8	8	7	0.875	0.0355029585798817	18	19	11	0	0.188499067635728	1
"263"	"GRB2:SOS provides linkage to MAPK signaling for Integrins"	15	15	4	0.266666666666667	15	15	13	0.866666666666667	0.171597633136095	87	103	19	0	0.196002164944112	1
"369"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	15	15	3	0.2	15	15	13	0.866666666666667	0.0927021696252465	47	52	8	0	0.196002164944112	1
"371"	"p130Cas linkage to MAPK signaling for integrins"	15	15	3	0.2	15	15	13	0.866666666666667	0.165680473372781	84	100	19	0	0.196002164944112	1
"510"	"Prolactin receptor signaling"	15	15	2	0.133333333333333	15	15	13	0.866666666666667	0.0887573964497041	45	48	9	0	0.196002164944112	1
"699"	"WNT5A-dependent internalization of FZD4"	15	15	1	0.0666666666666667	15	15	13	0.866666666666667	0.0867850098619329	44	51	11	0	0.196002164944112	1
"326"	"Ca-dependent events"	28	28	6	0.214285714285714	28	28	24	0.857142857142857	0.272189349112426	138	173	25	0	0.199586512555844	1
"583"	"PPARA activates gene expression"	111	111	12	0.108108108108108	111	111	93	0.837837837837838	0.485207100591716	246	424	32	0	0.205807193798391	1
"19"	"Signalling to RAS"	34	34	18	0.529411764705882	34	34	29	0.852941176470588	0.199211045364892	101	117	28	0	0.205991654861958	1
"173"	"Hedgehog ligand biogenesis"	64	64	20	0.3125	64	64	54	0.84375	0.19723865877712	100	127	10	0	0.210189093230833	1
"174"	"Processing-defective Hh variants abrogate ligand secretion"	64	64	20	0.3125	64	64	54	0.84375	0.19723865877712	100	127	10	0	0.210189093230833	1
"272"	"DAP12 interactions"	179	179	46	0.256983240223464	179	179	149	0.832402234636871	0.714003944773176	362	825	85	0	0.210966149205362	1
"142"	"Hh ligand biogenesis disease"	58	58	20	0.344827586206897	58	58	49	0.844827586206897	0.16370808678501	83	102	8	0	0.211182455657952	1
"165"	"CDT1 association with the CDC6:ORC:origin complex"	58	58	19	0.327586206896552	58	58	49	0.844827586206897	0.173570019723866	88	102	8	0	0.211182455657952	1
"802"	"formation of the beta-catenin:TCF transactivating complex"	58	58	2	0.0344827586206897	58	58	49	0.844827586206897	0.414201183431953	210	287	53	0	0.211182455657952	1
"757"	"Mitochondrial tRNA aminoacylation"	21	21	1	0.0476190476190476	21	21	18	0.857142857142857	0.100591715976331	51	61	7	0	0.214872470563385	1
"193"	"Recycling pathway of L1"	27	27	8	0.296296296296296	27	27	23	0.851851851851852	0.179487179487179	91	107	16	0	0.224235759800447	1
"735"	"DNA Repair"	115	115	6	0.0521739130434783	115	115	96	0.834782608695652	0.455621301775148	231	423	23	0	0.22832642427461	1
"119"	"Toll Like Receptor 9 (TLR9) Cascade"	92	92	34	0.369565217391304	92	92	77	0.83695652173913	0.355029585798817	180	285	10	0	0.228814193775876	1
"539"	"Metabolism of steroid hormones and vitamin D"	33	33	4	0.121212121212121	33	33	28	0.848484848484849	0.216962524654832	110	133	36	0	0.228878045871055	1
"541"	"Steroid hormones"	33	33	4	0.121212121212121	33	33	28	0.848484848484849	0.216962524654832	110	133	36	0	0.228878045871055	1
"828"	"Sialic acid metabolism"	33	33	1	0.0303030303030303	33	33	28	0.848484848484849	0.118343195266272	60	70	6	0	0.228878045871055	1
"329"	"Regulation of AMPK activity via LKB1"	14	14	3	0.214285714285714	14	14	12	0.857142857142857	0.0690335305719921	35	36	5	0	0.228997865336517	1
"467"	"Regulation of IFNG signaling"	14	14	2	0.142857142857143	14	14	12	0.857142857142857	0.0650887573964497	33	34	7	0	0.228997865336517	1
"685"	"Regulation of pyruvate dehydrogenase (PDH) complex"	14	14	1	0.0714285714285714	14	14	12	0.857142857142857	0.0611439842209073	31	32	6	0	0.228997865336517	1
"201"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	86	86	25	0.290697674418605	86	86	72	0.837209302325581	0.270216962524655	137	181	15	0	0.232206086676223	1
"209"	"FGFR3b ligand binding and activation"	7	7	2	0.285714285714286	7	7	6	0.857142857142857	0.0355029585798817	18	18	9	0	0.23224254874835	1
"458"	"Clearance of Nuclear Envelope Membranes from Chromatin"	7	7	1	0.142857142857143	7	7	6	0.857142857142857	0.0236686390532544	12	12	3	0	0.23224254874835	1
"460"	"Homologous DNA pairing and strand exchange"	7	7	1	0.142857142857143	7	7	6	0.857142857142857	0.0690335305719921	35	38	16	0	0.23224254874835	1
"461"	"Interleukin-1 processing"	7	7	1	0.142857142857143	7	7	6	0.857142857142857	0.0216962524654832	11	12	4	0	0.23224254874835	1
"464"	"Pentose phosphate pathway (hexose monophosphate shunt)"	7	7	1	0.142857142857143	7	7	6	0.857142857142857	0.0236686390532544	12	12	4	0	0.23224254874835	1
"220"	"PI3K/AKT activation"	103	103	29	0.281553398058252	103	103	86	0.83495145631068	0.52465483234714	266	453	85	0	0.235958214214195	1
"829"	"MHC class II antigen presentation"	103	103	3	0.029126213592233	103	103	86	0.83495145631068	0.406311637080868	206	326	18	0	0.235958214214195	1
"355"	"Formation of tubulin folding intermediates by CCT/TriC"	20	20	4	0.2	20	20	17	0.85	0.0729783037475345	37	42	9	0	0.244593807408081	1
"361"	"Regulation of gene expression in beta cells"	20	20	4	0.2	20	20	17	0.85	0.108481262327416	55	61	8	0	0.244593807408081	1
"700"	"Mitotic Prometaphase"	108	108	7	0.0648148148148148	108	108	90	0.833333333333333	0.378698224852071	192	315	13	0	0.246067537985482	1
"668"	"Fatty acid, triacylglycerol, and ketone body metabolism"	181	181	14	0.0773480662983425	181	181	150	0.828729281767956	0.601577909270217	305	633	32	0	0.249849497315065	1
"495"	"Nuclear Envelope Breakdown"	50	50	7	0.14	50	50	42	0.84	0.220907297830375	112	155	11	0	0.250631517635979	1
"374"	"CaM pathway"	26	26	5	0.192307692307692	26	26	22	0.846153846153846	0.254437869822485	129	163	25	0	0.251229765136078	1
"375"	"Calmodulin induced events"	26	26	5	0.192307692307692	26	26	22	0.846153846153846	0.254437869822485	129	163	25	0	0.251229765136078	1
"786"	"Insulin receptor recycling"	26	26	1	0.0384615384615385	26	26	22	0.846153846153846	0.0749506903353057	38	49	6	0	0.251229765136078	1
"742"	"Platelet homeostasis"	79	79	4	0.0506329113924051	79	79	66	0.835443037974684	0.428007889546351	217	361	43	0	0.251940359821367	1
"61"	"Signalling to ERKs"	44	44	19	0.431818181818182	44	44	37	0.840909090909091	0.244575936883629	124	156	28	0	0.252634419559509	1
"528"	"Regulation of beta-cell development"	32	32	4	0.125	32	32	27	0.84375	0.26232741617357	133	153	66	0	0.253657213423307	1
"109"	"MyD88:Mal cascade initiated on plasma membrane"	96	96	36	0.375	96	96	80	0.833333333333333	0.36094674556213	183	276	16	0	0.254925430060795	1
"113"	"Toll Like Receptor 2 (TLR2) Cascade"	96	96	36	0.375	96	96	80	0.833333333333333	0.36094674556213	183	276	16	0	0.254925430060795	1
"114"	"Toll Like Receptor TLR1:TLR2 Cascade"	96	96	36	0.375	96	96	80	0.833333333333333	0.36094674556213	183	276	16	0	0.254925430060795	1
"115"	"Toll Like Receptor TLR6:TLR2 Cascade"	96	96	36	0.375	96	96	80	0.833333333333333	0.36094674556213	183	276	16	0	0.254925430060795	1
"727"	"Antiviral mechanism by IFN-stimulated genes"	73	73	4	0.0547945205479452	73	73	61	0.835616438356164	0.284023668639053	144	229	15	0	0.256033803366926	1
"728"	"ISG15 antiviral mechanism"	73	73	4	0.0547945205479452	73	73	61	0.835616438356164	0.284023668639053	144	229	15	0	0.256033803366926	1
"171"	"Toll Like Receptor 4 (TLR4) Cascade"	124	124	39	0.314516129032258	124	124	103	0.830645161290323	0.463510848126233	235	402	42	0	0.260140315591314	1
"178"	"p75NTR recruits signalling complexes"	13	13	4	0.307692307692308	13	13	11	0.846153846153846	0.0591715976331361	30	34	9	0	0.266742686950578	1
"301"	"Signaling by Activin"	13	13	3	0.230769230769231	13	13	11	0.846153846153846	0.0769230769230769	39	40	10	0	0.266742686950578	1
"445"	"Platelet Adhesion to exposed collagen"	13	13	2	0.153846153846154	13	13	11	0.846153846153846	0.0946745562130177	48	55	12	0	0.266742686950578	1
"673"	"Initiation of Nuclear Envelope Reformation"	13	13	1	0.0769230769230769	13	13	11	0.846153846153846	0.0512820512820513	26	26	7	0	0.266742686950578	1
"675"	"Nuclear Envelope Reassembly"	13	13	1	0.0769230769230769	13	13	11	0.846153846153846	0.0512820512820513	26	26	7	0	0.266742686950578	1
"448"	"Transcriptional regulation of white adipocyte differentiation"	78	78	12	0.153846153846154	78	78	65	0.833333333333333	0.408284023668639	207	323	32	0	0.269039892182189	1
"740"	"Gene Expression"	1164	1164	59	0.0506872852233677	1164	1164	952	0.81786941580756	0.942800788954635	478	3544	66	0	0.270727072944282	1
"229"	"Removal of licensing factors from origins"	72	72	20	0.277777777777778	72	72	60	0.833333333333333	0.2465483234714	125	151	10	0	0.273963739874624	1
"763"	"Iron uptake and transport"	43	43	2	0.0465116279069767	43	43	36	0.837209302325581	0.149901380670611	76	104	12	0	0.275432704846491	1
"734"	"Synthesis of PC"	19	19	1	0.0526315789473684	19	19	16	0.842105263157895	0.0848126232741617	43	49	7	0	0.277547544095114	1
"816"	"Elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.126232741617357	64	73	10	0	0.280369240409506	1
"817"	"HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.126232741617357	64	73	10	0	0.280369240409506	1
"818"	"Pausing and recovery of HIV elongation"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.126232741617357	64	73	10	0	0.280369240409506	1
"819"	"Pausing and recovery of Tat-mediated HIV elongation"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.124260355029586	63	73	10	0	0.280369240409506	1
"822"	"Tat-mediated HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	26	0.838709677419355	0.124260355029586	63	73	10	0	0.280369240409506	1
"356"	"G0 and Early G1"	25	25	5	0.2	25	25	21	0.84	0.132149901380671	67	71	11	0	0.280648551932687	1
"223"	"PI-3K cascade"	100	100	28	0.28	100	100	83	0.83	0.516765285996055	262	440	85	0	0.281095671697924	1
"224"	"PI3K events in ERBB2 signaling"	100	100	28	0.28	100	100	83	0.83	0.516765285996055	262	440	85	0	0.281095671697924	1
"225"	"PI3K events in ERBB4 signaling"	100	100	28	0.28	100	100	83	0.83	0.516765285996055	262	440	85	0	0.281095671697924	1
"226"	"PI3K/AKT Signaling in Cancer"	100	100	28	0.28	100	100	83	0.83	0.516765285996055	262	440	85	0	0.281095671697924	1
"227"	"PIP3 activates AKT signaling"	100	100	28	0.28	100	100	83	0.83	0.516765285996055	262	440	85	0	0.281095671697924	1
"746"	"Resolution of Sister Chromatid Cohesion"	100	100	5	0.05	100	100	83	0.83	0.349112426035503	177	279	13	0	0.281095671697924	1
"153"	"FGFR2b ligand binding and activation"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.019723865877712	10	10	3	0	0.286128523865918	1
"155"	"Phosphorylation of Emi1"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.0177514792899408	9	9	3	0	0.286128523865918	1
"162"	"Uptake and function of diphtheria toxin"	6	6	2	0.333333333333333	6	6	5	0.833333333333333	0.0394477317554241	20	20	7	0	0.286128523865918	1
"412"	"IRF3 mediated activation of type 1 IFN"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0355029585798817	18	20	10	0	0.286128523865918	1
"413"	"IRS activation"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0216962524654832	11	11	4	0	0.286128523865918	1
"415"	"Mineralocorticoid biosynthesis"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0216962524654832	11	11	3	0	0.286128523865918	1
"417"	"Presynaptic phase of homologous DNA pairing and strand exchange"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0493096646942801	25	27	16	0	0.286128523865918	1
"422"	"Synthesis of 15-eicosatetraenoic acid derivatives"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0236686390532544	12	12	6	0	0.286128523865918	1
"425"	"Telomere Extension By Telomerase"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0177514792899408	9	10	4	0	0.286128523865918	1
"427"	"vRNP Assembly"	6	6	1	0.166666666666667	6	6	5	0.833333333333333	0.0374753451676529	19	19	9	0	0.286128523865918	1
"118"	"degradation of AXIN"	54	54	20	0.37037037037037	54	54	45	0.833333333333333	0.175542406311637	89	108	8	0	0.289273433332307	1
"98"	"MyD88 dependent cascade initiated on endosome"	88	88	34	0.386363636363636	88	88	73	0.829545454545455	0.333333333333333	169	262	10	0	0.292759932455876	1
"99"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	88	88	34	0.386363636363636	88	88	73	0.829545454545455	0.333333333333333	169	262	10	0	0.292759932455876	1
"394"	"beta-catenin independent WNT signaling"	144	144	25	0.173611111111111	144	144	119	0.826388888888889	0.467455621301775	237	429	20	0	0.293229006136614	1
"131"	"MyD88-independent cascade"	99	99	35	0.353535353535354	99	99	82	0.828282828282828	0.408284023668639	207	322	42	0	0.297247250225965	1
"132"	"TRIF-mediated TLR3/TLR4 signaling"	99	99	35	0.353535353535354	99	99	82	0.828282828282828	0.408284023668639	207	322	42	0	0.297247250225965	1
"133"	"Toll Like Receptor 3 (TLR3) Cascade"	99	99	35	0.353535353535354	99	99	82	0.828282828282828	0.408284023668639	207	322	42	0	0.297247250225965	1
"574"	"Metabolism of amino acids and derivatives"	188	188	21	0.111702127659574	188	188	155	0.824468085106383	0.465483234714004	236	380	11	0	0.297963664326075	1
"243"	"AMER1 mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"244"	"APC truncation mutants are not K63 polyubiquitinated"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"245"	"APC truncation mutants have impaired AXIN binding"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"246"	"AXIN missense mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"247"	"AXIN mutants destabilize the destruction complex, activating WNT signaling"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"249"	"Degradation of beta-catenin by the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"251"	"S33 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"252"	"S37 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"253"	"S45 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"254"	"T41 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"255"	"TCF7L2 mutants don't bind CTBP"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"256"	"deletions in the AMER1 gene destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"257"	"deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"258"	"misspliced GSK3beta mutants stabilize beta-catenin"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"259"	"phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"260"	"truncated APC mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"261"	"truncations of AMER1 destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	68	0.829268292682927	0.276134122287968	140	192	19	0	0.298949947428163	1
"404"	"Amine ligand-binding receptors"	42	42	7	0.166666666666667	42	42	35	0.833333333333333	0.187376725838264	95	123	9	0	0.299601364754403	1
"428"	"Cytokine Signaling in Immune system"	308	308	51	0.165584415584416	308	308	253	0.821428571428571	0.717948717948718	364	965	85	0	0.307065974268724	1
"204"	"GAB1 signalosome"	104	104	30	0.288461538461538	104	104	86	0.826923076923077	0.518737672583826	263	445	85	0	0.30717306889487	1
"405"	"Bile salt and organic anion SLC transporters"	12	12	2	0.166666666666667	12	12	10	0.833333333333333	0.0591715976331361	30	32	9	0	0.309663383197356	1
"416"	"P2Y receptors"	12	12	2	0.166666666666667	12	12	10	0.833333333333333	0.0473372781065089	24	26	7	0	0.309663383197356	1
"656"	"Death Receptor Signalling"	12	12	1	0.0833333333333333	12	12	10	0.833333333333333	0.11439842209073	58	62	42	0	0.309663383197356	1
"145"	"Activated TLR4 signalling"	115	115	39	0.339130434782609	115	115	95	0.826086956521739	0.445759368836292	226	355	42	0	0.309867295101026	1
"589"	"Defective AMN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"590"	"Defective BTD causes biotidinase deficiency"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"591"	"Defective CD320 causes methylmalonic aciduria"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"592"	"Defective CUBN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"593"	"Defective GIF causes intrinsic factor deficiency"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"594"	"Defective HLCS causes multiple carboxylase deficiency"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"595"	"Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"596"	"Defective MMAA causes methylmalonic aciduria type cblA"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"597"	"Defective MMAB causes methylmalonic aciduria type cblB"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"598"	"Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"599"	"Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"600"	"Defective MTR causes methylmalonic aciduria and homocystinuria type cblG"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"601"	"Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"602"	"Defective MUT causes methylmalonic aciduria mut type"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"603"	"Defective TCN2 causes hereditary megaloblastic anemia"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"604"	"Defects in biotin (Btn) metabolism"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"605"	"Defects in cobalamin (B12) metabolism"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"606"	"Defects in vitamin and cofactor metabolism"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"607"	"Metabolism of vitamins and cofactors"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"608"	"Metabolism of water-soluble vitamins and cofactors"	87	87	9	0.103448275862069	87	87	72	0.827586206896552	0.362919132149901	184	264	33	0	0.310304179681352	1
"211"	"Orc1 removal from chromatin"	70	70	20	0.285714285714286	70	70	58	0.828571428571429	0.240631163708087	122	146	10	0	0.312167751892842	1
"214"	"Switching of origins to a post-replicative state"	70	70	20	0.285714285714286	70	70	58	0.828571428571429	0.240631163708087	122	146	10	0	0.312167751892842	1
"558"	"Loss of Function of SMAD2/3 in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"559"	"Loss of Function of SMAD4 in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"560"	"Loss of Function of TGFBR1 in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"561"	"Loss of Function of TGFBR2 in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"563"	"SMAD2/3 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"564"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"565"	"SMAD4 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"566"	"Signaling by TGF-beta Receptor Complex"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"567"	"Signaling by TGF-beta Receptor Complex in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"568"	"TGFBR1 KD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"569"	"TGFBR1 LBD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"570"	"TGFBR2 Kinase Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"571"	"TGFBR2 MSI Frameshift Mutants in Cancer"	70	70	8	0.114285714285714	70	70	58	0.828571428571429	0.355029585798817	180	269	20	0	0.312167751892842	1
"70"	"Nuclear Events (kinase and transcription factor activation)"	24	24	10	0.416666666666667	24	24	20	0.833333333333333	0.126232741617357	64	68	10	0	0.312541680745451	1
"575"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	18	18	2	0.111111111111111	18	18	15	0.833333333333333	0.0907297830374754	46	53	16	0	0.313870448859543	1
"197"	"Downstream signaling events of B Cell Receptor (BCR)"	170	170	50	0.294117647058824	170	170	140	0.823529411764706	0.6232741617357	316	613	85	0	0.315971321696019	1
"650"	"Interferon gamma signaling"	92	92	8	0.0869565217391304	92	92	76	0.826086956521739	0.337278106508876	171	253	13	0	0.321009167423888	1
"265"	"Regulation of DNA replication"	75	75	20	0.266666666666667	75	75	62	0.826666666666667	0.250493096646943	127	156	10	0	0.324647647837169	1
"90"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	86	86	34	0.395348837209302	86	86	71	0.825581395348837	0.323471400394477	164	251	10	0	0.328441610393959	1
"918"	"Post-translational protein modification"	278	278	2	0.00719424460431655	278	278	228	0.820143884892086	0.741617357001972	376	1049	92	0	0.334496877027437	1
"75"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	52	52	21	0.403846153846154	52	52	43	0.826923076923077	0.157790927021696	80	95	14	0	0.334616196994487	1
"76"	"p53-Independent DNA Damage Response"	52	52	21	0.403846153846154	52	52	43	0.826923076923077	0.157790927021696	80	95	14	0	0.334616196994487	1
"77"	"p53-Independent G1/S DNA damage checkpoint"	52	52	21	0.403846153846154	52	52	43	0.826923076923077	0.157790927021696	80	95	14	0	0.334616196994487	1
"122"	"Stabilization of p53"	52	52	19	0.365384615384615	52	52	43	0.826923076923077	0.575936883629191	292	352	257	0	0.334616196994487	1
"376"	"Mitochondrial biogenesis"	52	52	10	0.192307692307692	52	52	43	0.826923076923077	0.289940828402367	147	200	29	0	0.334616196994487	1
"180"	"Asymmetric localization of PCP proteins"	63	63	19	0.301587301587302	63	63	52	0.825396825396825	0.191321499013807	97	121	9	0	0.340624785985048	1
"323"	"FGFR ligand binding and activation"	23	23	5	0.217391304347826	23	23	19	0.826086956521739	0.0946745562130177	48	50	9	0	0.346919762044051	1
"901"	"Asparagine N-linked glycosylation"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"902"	"Defective ALG1 causes ALG1-CDG (CDG-1k)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"903"	"Defective ALG11 causes ALG11-CDG (CDG-1p)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"904"	"Defective ALG12 causes ALG12-CDG (CDG-1g)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"905"	"Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"906"	"Defective ALG2 causes ALG2-CDG (CDG-1i)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"907"	"Defective ALG3 causes ALG3-CDG (CDG-1d)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"908"	"Defective ALG6 causes ALG6-CDG (CDG-1c)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"909"	"Defective ALG8 causes ALG8-CDG (CDG-1h)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"910"	"Defective ALG9 causes ALG9-CDG (CDG-1l)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"911"	"Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"912"	"Defective MAN1B1 causes MRT15"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"913"	"Defective MGAT2 causes MGAT2-CDG (CDG-2a)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"914"	"Defective MOGS causes MOGS-CDG (CDG-2b)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"915"	"Defective MPDU1 causes MPDU1-CDG (CDG-1f)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"916"	"Defective RFT1 causes RFT1-CDG (CDG-1n)"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"917"	"Diseases associated with N-glycosylation of proteins"	118	118	1	0.00847457627118644	118	118	97	0.822033898305085	0.349112426035503	177	263	8	0	0.350408872549039	1
"234"	"Negative regulation of FGFR signaling"	40	40	11	0.275	40	40	33	0.825	0.151873767258383	77	89	9	0	0.351963181305884	1
"8"	"G2/M DNA replication checkpoint"	5	5	3	0.6	5	5	4	0.8	0.00986193293885602	5	5	2	0	0.35250664345743	1
"84"	"PKA-mediated phosphorylation of key metabolic factors"	5	5	2	0.4	5	5	4	0.8	0.0236686390532544	12	12	4	0	0.35250664345743	1
"352"	"Assembly of the RAD51-ssDNA nucleoprotein complex"	5	5	1	0.2	5	5	4	0.8	0.0216962524654832	11	11	5	0	0.35250664345743	1
"354"	"Cyclin B2 mediated events"	5	5	1	0.2	5	5	4	0.8	0.0177514792899408	9	9	3	0	0.35250664345743	1
"362"	"S6K1 signalling"	5	5	1	0.2	5	5	4	0.8	0.0532544378698225	27	27	15	0	0.35250664345743	1
"363"	"SMAC binds to IAPs"	5	5	1	0.2	5	5	4	0.8	0.0157790927021696	8	8	3	0	0.35250664345743	1
"364"	"SMAC-mediated apoptotic response"	5	5	1	0.2	5	5	4	0.8	0.0157790927021696	8	8	3	0	0.35250664345743	1
"365"	"SMAC-mediated dissociation of IAP:caspase complexes"	5	5	1	0.2	5	5	4	0.8	0.0157790927021696	8	8	3	0	0.35250664345743	1
"390"	"KSRP destabilizes mRNA"	17	17	3	0.176470588235294	17	17	14	0.823529411764706	0.0453648915187377	23	23	4	0	0.353644094882067	1
"550"	"Homologous Recombination Repair"	17	17	2	0.117647058823529	17	17	14	0.823529411764706	0.167652859960552	85	105	16	0	0.353644094882067	1
"551"	"Homologous recombination repair of replication-independent double-strand breaks"	17	17	2	0.117647058823529	17	17	14	0.823529411764706	0.167652859960552	85	105	16	0	0.353644094882067	1
"554"	"PKA-mediated phosphorylation of CREB"	17	17	2	0.117647058823529	17	17	14	0.823529411764706	0.193293885601578	98	114	25	0	0.353644094882067	1
"556"	"Platelet sensitization by LDL"	17	17	2	0.117647058823529	17	17	14	0.823529411764706	0.134122287968442	68	77	43	0	0.353644094882067	1
"235"	"Condensation of Prometaphase Chromosomes"	11	11	3	0.272727272727273	11	11	9	0.818181818181818	0.0749506903353057	38	39	7	0	0.35812930386222	1
"634"	"Androgen biosynthesis"	11	11	1	0.0909090909090909	11	11	9	0.818181818181818	0.0335305719921105	17	17	3	0	0.35812930386222	1
"641"	"Nicotinate metabolism"	11	11	1	0.0909090909090909	11	11	9	0.818181818181818	0.0591715976331361	30	31	7	0	0.35812930386222	1
"117"	"Autodegradation of the E3 ubiquitin ligase COP1"	51	51	19	0.372549019607843	51	51	42	0.823529411764706	0.571992110453649	290	349	257	0	0.358781136737847	1
"18"	"EPHA-mediated growth cone collapse"	34	34	18	0.529411764705882	34	34	28	0.823529411764706	0.32741617357002	166	239	24	0	0.361619113723817	1
"391"	"Platelet activation, signaling and aggregation"	221	221	39	0.176470588235294	221	221	181	0.819004524886878	0.775147928994083	393	1059	187	0	0.363343623675819	1
"695"	"RMTs methylate histone arginines"	45	45	3	0.0666666666666667	45	45	37	0.822222222222222	0.2465483234714	125	168	21	0	0.368946927704612	1
"793"	"mRNA Capping"	28	28	1	0.0357142857142857	28	28	23	0.821428571428571	0.112426035502959	57	66	10	0	0.372131243268064	1
"231"	"Toll-Like Receptors Cascades"	144	144	40	0.277777777777778	144	144	118	0.819444444444444	0.502958579881657	255	471	42	0	0.372764011954307	1
"144"	"degradation of DVL"	56	56	19	0.339285714285714	56	56	46	0.821428571428571	0.199211045364892	101	119	11	0	0.372893021412606	1
"890"	"Regulatory RNA pathways"	100	100	1	0.01	100	100	82	0.82	0.388560157790927	197	331	12	0	0.376104957156992	1
"306"	"Extrinsic Pathway"	22	22	5	0.227272727272727	22	22	18	0.818181818181818	0.193293885601578	98	114	42	0	0.383745122840367	1
"504"	"Cholesterol biosynthesis"	22	22	3	0.136363636363636	22	22	18	0.818181818181818	0.0611439842209073	31	34	5	0	0.383745122840367	1
"771"	"Pyruvate metabolism"	22	22	1	0.0454545454545455	22	22	18	0.818181818181818	0.0729783037475345	37	40	6	0	0.383745122840367	1
"68"	"Ubiquitin-dependent degradation of Cyclin D"	50	50	21	0.42	50	50	41	0.82	0.138067061143984	70	80	8	0	0.383880707041353	1
"69"	"Ubiquitin-dependent degradation of Cyclin D1"	50	50	21	0.42	50	50	41	0.82	0.138067061143984	70	80	8	0	0.383880707041353	1
"85"	"Regulation of Apoptosis"	50	50	20	0.4	50	50	41	0.82	0.143984220907298	73	85	8	0	0.383880707041353	1
"623"	"Ca2+ pathway"	61	61	6	0.0983606557377049	61	61	50	0.819672131147541	0.289940828402367	147	217	20	0	0.385649431221627	1
"540"	"Nuclear Pore Complex (NPC) Disassembly"	33	33	4	0.121212121212121	33	33	27	0.818181818181818	0.16370808678501	83	111	11	0	0.392420551715921	1
"12"	"Regulation of KIT signaling"	16	16	9	0.5625	16	16	13	0.8125	0.0887573964497041	45	51	8	0	0.396874755371351	1
"112"	"Spry regulation of FGF signaling"	16	16	6	0.375	16	16	13	0.8125	0.0650887573964497	33	38	9	0	0.396874755371351	1
"871"	"GABA receptor activation"	55	55	1	0.0181818181818182	55	55	45	0.818181818181818	0.337278106508876	171	253	25	0	0.397199006614995	1
"120"	"G1/S DNA Damage Checkpoints"	60	60	22	0.366666666666667	60	60	49	0.816666666666667	0.583826429980276	296	366	257	0	0.409214900244237	1
"74"	"Regulation of activated PAK-2p34 by proteasome mediated degradation"	49	49	20	0.408163265306122	49	49	40	0.816326530612245	0.138067061143984	70	81	8	0	0.409853256224897	1
"863"	"Muscle contraction"	49	49	1	0.0204081632653061	49	49	40	0.816326530612245	0.526627218934911	267	438	187	0	0.409853256224897	1
"86"	"Role of DCC in regulating apoptosis"	10	10	4	0.4	10	10	8	0.8	0.0986193293885602	50	52	23	0	0.41240292986026	1
"186"	"Netrin mediated repulsion signals"	10	10	3	0.3	10	10	8	0.8	0.143984220907298	73	82	23	0	0.41240292986026	1
"358"	"GP1b-IX-V activation signalling"	10	10	2	0.2	10	10	8	0.8	0.0808678500986193	41	45	18	0	0.41240292986026	1
"359"	"Nef Mediated CD4 Down-regulation"	10	10	2	0.2	10	10	8	0.8	0.0335305719921105	17	18	4	0	0.41240292986026	1
"619"	"Methylation"	10	10	1	0.1	10	10	8	0.8	0.0315581854043393	16	17	4	0	0.41240292986026	1
"620"	"Purine catabolism"	10	10	1	0.1	10	10	8	0.8	0.0493096646942801	25	26	7	0	0.41240292986026	1
"621"	"Regulated proteolysis of p75NTR"	10	10	1	0.1	10	10	8	0.8	0.0394477317554241	20	20	5	0	0.41240292986026	1
"511"	"Cell Cycle"	518	518	68	0.131274131274131	518	518	422	0.814671814671815	0.942800788954635	478	2050	257	0	0.412847210436239	1
"827"	"Transcription of the HIV genome"	65	65	2	0.0307692307692308	65	65	53	0.815384615384615	0.252465483234714	128	171	20	0	0.420160714777604	1
"136"	"AUF1 (hnRNP D0) destabilizes mRNA"	54	54	19	0.351851851851852	54	54	44	0.814814814814815	0.167652859960552	85	102	15	0	0.422241249391319	1
"498"	"Transcriptional activation of mitochondrial biogenesis"	43	43	6	0.13953488372093	43	43	35	0.813953488372093	0.268244575936884	136	183	29	0	0.423897329995097	1
"526"	"Oncogene Induced Senescence"	32	32	4	0.125	32	32	26	0.8125	0.625246548323471	317	421	257	0	0.424614186134975	1
"322"	"S Phase"	124	124	27	0.217741935483871	124	124	101	0.814516129032258	0.3767258382643	191	278	10	0	0.432322372148782	1
"129"	"Degradation of GLI1 by the proteasome"	59	59	21	0.355932203389831	59	59	48	0.813559322033898	0.191321499013807	97	112	8	0	0.433405995532525	1
"284"	"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes"	4	4	1	0.25	4	4	3	0.75	0.0335305719921105	17	17	10	0	0.434270419907901	1
"286"	"SHC activation"	4	4	1	0.25	4	4	3	0.75	0.0118343195266272	6	6	2	0	0.434270419907901	1
"89"	"MyD88 cascade initiated on plasma membrane"	86	86	34	0.395348837209302	86	86	70	0.813953488372093	0.319526627218935	162	241	10	0	0.435702418801499	1
"91"	"Toll Like Receptor 10 (TLR10) Cascade"	86	86	34	0.395348837209302	86	86	70	0.813953488372093	0.319526627218935	162	241	10	0	0.435702418801499	1
"92"	"Toll Like Receptor 5 (TLR5) Cascade"	86	86	34	0.395348837209302	86	86	70	0.813953488372093	0.319526627218935	162	241	10	0	0.435702418801499	1
"655"	"Chaperonin-mediated protein folding"	48	48	4	0.0833333333333333	48	48	39	0.8125	0.209072978303748	106	133	25	0	0.436623854491762	1
"302"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	26	26	6	0.230769230769231	26	26	21	0.807692307692308	0.138067061143984	70	84	9	0	0.442451879314034	1
"787"	"RNA Pol II CTD phosphorylation and interaction with CE"	26	26	1	0.0384615384615385	26	26	21	0.807692307692308	0.0986193293885602	50	58	10	0	0.442451879314034	1
"318"	"Oxidative Stress Induced Senescence"	91	91	20	0.21978021978022	91	91	74	0.813186813186813	0.692307692307692	351	560	257	0	0.443795207204159	1
"266"	"Signaling by the B Cell Receptor (BCR)"	209	209	55	0.263157894736842	209	209	170	0.813397129186603	0.674556213017751	342	763	85	0	0.447706850219864	1
"750"	"Formation of HIV elongation complex in the absence of HIV Tat"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.16370808678501	83	97	10	0	0.452731572580966	1
"751"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.161735700197239	82	97	10	0	0.452731572580966	1
"752"	"Formation of RNA Pol II elongation complex"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.16370808678501	83	97	10	0	0.452731572580966	1
"755"	"HIV Transcription Elongation"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.161735700197239	82	97	10	0	0.452731572580966	1
"759"	"RNA Polymerase II Transcription Elongation"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.16370808678501	83	97	10	0	0.452731572580966	1
"760"	"Tat-mediated elongation of the HIV-1 transcript"	42	42	2	0.0476190476190476	42	42	34	0.80952380952381	0.161735700197239	82	97	10	0	0.452731572580966	1
"839"	"Triglyceride Biosynthesis"	42	42	1	0.0238095238095238	42	42	34	0.80952380952381	0.19723865877712	100	116	17	0	0.452731572580966	1
"721"	"Glucose metabolism"	69	69	4	0.0579710144927536	69	69	56	0.811594202898551	0.242603550295858	123	169	11	0	0.45290460428609	1
"795"	"Meiosis"	85	85	3	0.0352941176470588	85	85	69	0.811764705882353	0.518737672583826	263	435	79	0	0.456246605267651	1
"753"	"GPCR downstream signaling"	966	966	46	0.0476190476190476	966	966	785	0.812629399585921	0.942800788954635	478	3302	85	0	0.457743255821838	1
"624"	"The phototransduction cascade"	31	31	3	0.0967741935483871	31	31	25	0.806451612903226	0.128205128205128	65	83	10	0	0.458074150040495	1
"625"	"disassembly of the destruction complex and recruitment of AXIN to the membrane"	31	31	3	0.0967741935483871	31	31	25	0.806451612903226	0.191321499013807	97	119	19	0	0.458074150040495	1
"614"	"Cobalamin (Cbl, vitamin B12) transport and metabolism"	20	20	2	0.1	20	20	16	0.8	0.128205128205128	65	70	33	0	0.464285385321631	1
"651"	"Phospholipid metabolism"	138	138	12	0.0869565217391304	138	138	112	0.811594202898551	0.57396449704142	291	501	85	0	0.467713245462843	1
"58"	"Nef and signal transduction"	9	9	4	0.444444444444444	9	9	7	0.777777777777778	0.0946745562130177	48	50	13	0	0.472570599709614	1
"868"	"Synthesis of substrates in N-glycan biosythesis"	52	52	1	0.0192307692307692	52	52	42	0.807692307692308	0.169625246548323	86	100	6	0	0.474235848845013	1
"275"	"Apoptosis"	148	148	38	0.256756756756757	148	148	120	0.810810810810811	0.743589743589744	377	702	257	0	0.478796482971005	1
"543"	"Cellular response to hypoxia"	25	25	3	0.12	25	25	20	0.8	0.191321499013807	97	113	32	0	0.47998060701246	1
"544"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	25	25	3	0.12	25	25	20	0.8	0.191321499013807	97	113	32	0	0.47998060701246	1
"455"	"Signaling by Retinoic Acid"	41	41	6	0.146341463414634	41	41	33	0.804878048780488	0.169625246548323	86	102	11	0	0.482329455363003	1
"537"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	41	41	5	0.121951219512195	41	41	33	0.804878048780488	0.234714003944773	119	166	18	0	0.482329455363003	1
"501"	"Gastrin-CREB signalling pathway via PKC and MAPK"	217	217	30	0.138248847926267	217	217	176	0.811059907834101	0.712031558185404	361	820	85	0	0.483362443231342	1
"139"	"p53-Dependent G1 DNA Damage Response"	57	57	20	0.350877192982456	57	57	46	0.807017543859649	0.581854043392505	295	361	257	0	0.483383056640744	1
"140"	"p53-Dependent G1/S DNA damage checkpoint"	57	57	20	0.350877192982456	57	57	46	0.807017543859649	0.581854043392505	295	361	257	0	0.483383056640744	1
"821"	"RNA Polymerase II Pre-transcription Events"	62	62	2	0.032258064516129	62	62	50	0.806451612903226	0.250493096646943	127	164	20	0	0.491730831915517	1
"612"	"Activation of the pre-replicative complex"	30	30	3	0.1	30	30	24	0.8	0.130177514792899	66	73	9	0	0.492641457342897	1
"617"	"Inactivation, recovery and regulation of the phototransduction cascade"	30	30	3	0.1	30	30	24	0.8	0.126232741617357	64	82	10	0	0.492641457342897	1
"472"	"TRAF3-dependent IRF activation pathway"	14	14	2	0.142857142857143	14	14	11	0.785714285714286	0.171597633136095	87	95	32	0	0.493211616634941	1
"276"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	51	51	13	0.254901960784314	51	51	41	0.803921568627451	0.289940828402367	147	193	42	0	0.501012035124378	1
"325"	"Cellular response to heat stress"	51	51	11	0.215686274509804	51	51	41	0.803921568627451	0.321499013806706	163	220	32	0	0.501012035124378	1
"867"	"RNA Polymerase II Transcription"	104	104	2	0.0192307692307692	104	104	84	0.807692307692308	0.309664694280079	157	245	20	0	0.50314558942221	1
"401"	"HSF1-dependent transactivation"	35	35	6	0.171428571428571	35	35	28	0.8	0.234714003944773	119	144	32	0	0.503306269076989	1
"646"	"Factors involved in megakaryocyte development and platelet production"	125	125	11	0.088	125	125	101	0.808	0.759368836291913	385	738	257	0	0.507243299476404	1
"436"	"Signaling by NODAL"	19	19	3	0.157894736842105	19	19	15	0.789473684210526	0.0867850098619329	44	45	10	0	0.507592607603165	1
"496"	"Mitotic Anaphase"	172	172	24	0.13953488372093	172	172	139	0.808139534883721	0.453648915187377	230	407	13	0	0.518302157143509	1
"248"	"DNA Replication Pre-Initiation"	82	82	22	0.268292682926829	82	82	66	0.804878048780488	0.244575936883629	124	157	9	0	0.519452422814035	1
"250"	"M/G1 Transition"	82	82	22	0.268292682926829	82	82	66	0.804878048780488	0.244575936883629	124	157	9	0	0.519452422814035	1
"351"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	45	45	9	0.2	45	45	36	0.8	0.248520710059172	126	172	18	0	0.52077129917812	1
"141"	"Activation of NF-kappaB in B cells"	66	66	23	0.348484848484849	66	66	53	0.803030303030303	0.222879684418146	113	137	10	0	0.523099936149217	1
"636"	"Cytosolic sensors of pathogen-associated DNA"	66	66	6	0.0909090909090909	66	66	53	0.803030303030303	0.319526627218935	162	240	32	0	0.523099936149217	1
"712"	"Signaling by GPCR"	1078	1078	66	0.0612244897959184	1078	1078	874	0.810760667903525	0.958579881656805	486	3604	85	0	0.524022564892081	1
"400"	"The role of Nef in HIV-1 replication and disease pathogenesis"	29	29	5	0.172413793103448	29	29	23	0.793103448275862	0.179487179487179	91	107	13	0	0.528122754648245	1
"609"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	29	29	3	0.103448275862069	29	29	23	0.793103448275862	0.155818540433925	79	92	11	0	0.528122754648245	1
"80"	"CDK-mediated phosphorylation and removal of Cdc6"	50	50	20	0.4	50	50	40	0.8	0.134122287968442	68	78	8	0	0.528172646949934	1
"781"	"IRE1alpha activates chaperones"	50	50	2	0.04	50	50	40	0.8	0.185404339250493	94	119	19	0	0.528172646949934	1
"148"	"Activation of BMF and translocation to mitochondria"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.00394477317554241	2	2	1	0	0.534983004369747	1
"152"	"Dopamine clearance from the synaptic cleft"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.00986193293885602	5	5	4	0	0.534983004369747	1
"156"	"Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0177514792899408	9	9	7	0	0.534983004369747	1
"157"	"Regulation of gap junction activity"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0236686390532544	12	12	10	0	0.534983004369747	1
"161"	"The NLRP1 inflammasome"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0157790927021696	8	8	7	0	0.534983004369747	1
"163"	"c-src mediated regulation of Cx43 function and closure of gap junctions"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0236686390532544	12	12	10	0	0.534983004369747	1
"335"	"Cell Cycle Checkpoints"	118	118	25	0.211864406779661	118	118	95	0.805084745762712	0.660749506903353	335	508	257	0	0.537376450174009	1
"108"	"Glucocorticoid biosynthesis"	8	8	3	0.375	8	8	6	0.75	0.0355029585798817	18	18	6	0	0.538446916536704	1
"110"	"Negative regulation of the PI3K/AKT network"	8	8	3	0.375	8	8	6	0.75	0.0552268244575937	28	29	10	0	0.538446916536704	1
"116"	"WNT mediated activation of DVL"	8	8	3	0.375	8	8	6	0.75	0.0631163708086785	32	34	8	0	0.538446916536704	1
"523"	"Host Interactions with Influenza Factors"	8	8	1	0.125	8	8	6	0.75	0.029585798816568	15	16	9	0	0.538446916536704	1
"267"	"Programmed Cell Death"	160	160	42	0.2625	160	160	129	0.80625	0.765285996055227	388	759	257	0	0.539916351331006	1
"288"	"Antigen processing-Cross presentation"	81	81	20	0.246913580246914	81	81	65	0.802469135802469	0.264299802761341	134	176	13	0	0.540866967986956	1
"177"	"Signal regulatory protein (SIRP) family interactions"	13	13	4	0.307692307692308	13	13	10	0.769230769230769	0.0749506903353057	38	40	9	0	0.545727212554634	1
"440"	"Advanced glycosylation endproduct receptor signaling"	13	13	2	0.153846153846154	13	13	10	0.769230769230769	0.0433925049309665	22	24	8	0	0.545727212554634	1
"441"	"FGFR2c ligand binding and activation"	13	13	2	0.153846153846154	13	13	10	0.769230769230769	0.0355029585798817	18	19	4	0	0.545727212554634	1
"442"	"FGFR4 ligand binding and activation"	13	13	2	0.153846153846154	13	13	10	0.769230769230769	0.0414201183431953	21	22	4	0	0.545727212554634	1
"669"	"Caspase-8 activation by cleavage"	13	13	1	0.0769230769230769	13	13	10	0.769230769230769	0.108481262327416	55	58	42	0	0.545727212554634	1
"670"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production"	13	13	1	0.0769230769230769	13	13	10	0.769230769230769	0.0690335305719921	35	37	8	0	0.545727212554634	1
"228"	"Fc epsilon receptor (FCERI) signaling"	212	212	59	0.278301886792453	212	212	171	0.806603773584906	0.686390532544379	348	799	85	0	0.54983811907199	1
"726"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	18	18	1	0.0555555555555556	18	18	14	0.777777777777778	0.0631163708086785	32	40	8	0	0.552512324994688	1
"73"	"Cross-presentation of soluble exogenous antigens (endosomes)"	49	49	20	0.408163265306122	49	49	39	0.795918367346939	0.14792899408284	75	83	9	0	0.555604291233383	1
"324"	"Signaling by BMP"	23	23	5	0.217391304347826	23	23	18	0.782608695652174	0.110453648915187	56	67	10	0	0.558665586622865	1
"775"	"BBSome-mediated cargo-targeting to cilium"	23	23	1	0.0434782608695652	23	23	18	0.782608695652174	0.102564102564103	52	59	6	0	0.558665586622865	1
"137"	"SCF-beta-TrCP mediated degradation of Emi1"	54	54	19	0.351851851851852	54	54	43	0.796296296296296	0.155818540433925	79	89	8	0	0.561056536470323	1
"823"	"Membrane Trafficking"	190	190	6	0.0315789473684211	190	190	153	0.805263157894737	0.58974358974359	299	661	26	0	0.562912919151576	1
"790"	"Dual incision reaction in TC-NER"	28	28	1	0.0357142857142857	28	28	22	0.785714285714286	0.128205128205128	65	74	10	0	0.564289937536294	1
"791"	"Formation of transcription-coupled NER (TC-NER) repair complex"	28	28	1	0.0357142857142857	28	28	22	0.785714285714286	0.128205128205128	65	74	10	0	0.564289937536294	1
"94"	"Degradation of GLI2 by the proteasome"	59	59	23	0.389830508474576	59	59	47	0.796610169491525	0.193293885601578	98	112	11	0	0.566147372739778	1
"95"	"GLI3 is processed to GLI3R by the proteasome"	59	59	23	0.389830508474576	59	59	47	0.796610169491525	0.183431952662722	93	110	9	0	0.566147372739778	1
"237"	"Purine metabolism"	33	33	9	0.272727272727273	33	33	26	0.787878787878788	0.130177514792899	66	76	8	0	0.569485541020721	1
"332"	"E2F mediated regulation of DNA replication"	33	33	7	0.212121212121212	33	33	26	0.787878787878788	0.122287968441815	62	71	10	0	0.569485541020721	1
"191"	"ER-Phagosome pathway"	64	64	19	0.296875	64	64	51	0.796875	0.209072978303748	106	133	13	0	0.57093388143111	1
"841"	"HIV Transcription Initiation"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"842"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.142011834319527	72	82	6	0	0.578881383894142	1
"843"	"RNA Polymerase II HIV Promoter Escape"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"844"	"RNA Polymerase II Promoter Escape"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"845"	"RNA Polymerase II Transcription Initiation"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"846"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"847"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	43	43	1	0.0232558139534884	43	43	34	0.790697674418605	0.193293885601578	98	117	20	0	0.578881383894142	1
"500"	"Mitotic Metaphase and Anaphase"	173	173	24	0.138728323699422	173	173	139	0.803468208092486	0.453648915187377	230	407	13	0	0.581096648634059	1
"861"	"XBP1(S) activates chaperone genes"	48	48	1	0.0208333333333333	48	48	38	0.791666666666667	0.181459566074951	92	114	19	0	0.583184714110299	1
"457"	"Cell Cycle, Mitotic"	445	445	64	0.143820224719101	445	445	359	0.806741573033708	0.826429980276134	419	1382	71	0	0.591281760692731	1
"546"	"Activated point mutants of FGFR2"	17	17	2	0.117647058823529	17	17	13	0.764705882352941	0.0433925049309665	22	23	4	0	0.598617837654675	1
"547"	"Beta-catenin phosphorylation cascade"	17	17	2	0.117647058823529	17	17	13	0.764705882352941	0.11439842209073	58	67	19	0	0.598617837654675	1
"548"	"Butyrate Response Factor 1 (BRF1) destabilizes mRNA"	17	17	2	0.117647058823529	17	17	13	0.764705882352941	0.0571992110453649	29	30	9	0	0.598617837654675	1
"549"	"FGFR2 ligand binding and activation"	17	17	2	0.117647058823529	17	17	13	0.764705882352941	0.0433925049309665	22	23	4	0	0.598617837654675	1
"557"	"Signaling by FGFR2 mutants"	17	17	2	0.117647058823529	17	17	13	0.764705882352941	0.0433925049309665	22	23	4	0	0.598617837654675	1
"719"	"Synthesis, secretion, and deacylation of Ghrelin"	17	17	1	0.0588235294117647	17	17	13	0.764705882352941	0.0493096646942801	25	25	6	0	0.598617837654675	1
"720"	"Tristetraprolin (TTP) destabilizes mRNA"	17	17	1	0.0588235294117647	17	17	13	0.764705882352941	0.0650887573964497	33	34	9	0	0.598617837654675	1
"640"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	22	22	2	0.0909090909090909	22	22	17	0.772727272727273	0.102564102564103	52	59	13	0	0.599217003837782	1
"1"	"Reversible hydration of carbon dioxide"	12	12	11	0.916666666666667	12	12	9	0.75	0.0355029585798817	18	19	5	0	0.600458907186539	1
"35"	"PECAM1 interactions"	12	12	6	0.5	12	12	9	0.75	0.0650887573964497	33	40	9	0	0.600458907186539	1
"407"	"FGFR3 ligand binding and activation"	12	12	2	0.166666666666667	12	12	9	0.75	0.0453648915187377	23	24	9	0	0.600458907186539	1
"408"	"FGFR3c ligand binding and activation"	12	12	2	0.166666666666667	12	12	9	0.75	0.0453648915187377	23	24	9	0	0.600458907186539	1
"414"	"Inhibition of replication initiation of damaged DNA by RB1/E2F1"	12	12	2	0.166666666666667	12	12	9	0.75	0.0552268244575937	28	30	10	0	0.600458907186539	1
"420"	"Signaling by FGFR3 mutants"	12	12	2	0.166666666666667	12	12	9	0.75	0.0453648915187377	23	24	9	0	0.600458907186539	1
"421"	"Signaling by activated point mutants of FGFR3"	12	12	2	0.166666666666667	12	12	9	0.75	0.0453648915187377	23	24	9	0	0.600458907186539	1
"659"	"Vitamin B5 (pantothenate) metabolism"	12	12	1	0.0833333333333333	12	12	9	0.75	0.0374753451676529	19	20	9	0	0.600458907186539	1
"452"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	27	27	4	0.148148148148148	27	27	21	0.777777777777778	0.0867850098619329	44	49	9	0	0.600880846705547	1
"788"	"Attenuation phase"	27	27	1	0.037037037037037	27	27	21	0.777777777777778	0.205128205128205	104	121	32	0	0.600880846705547	1
"825"	"Formation of the Early Elongation Complex"	32	32	1	0.03125	32	32	25	0.78125	0.122287968441815	62	69	10	0	0.60306732696441	1
"826"	"Formation of the HIV-1 Early Elongation Complex"	32	32	1	0.03125	32	32	25	0.78125	0.122287968441815	62	69	10	0	0.60306732696441	1
"471"	"Separation of Sister Chromatids"	161	161	23	0.142857142857143	161	161	129	0.801242236024845	0.437869822485207	222	384	13	0	0.604162620814193	1
"761"	"Transcriptional regulation of pluripotent stem cells"	42	42	2	0.0476190476190476	42	42	33	0.785714285714286	0.185404339250493	94	113	10	0	0.608120457186662	1
"648"	"Orphan transporters"	114	114	10	0.087719298245614	114	114	91	0.798245614035088	0.493096646942801	250	464	43	0	0.608551591790997	1
"4"	"CREB phosphorylation"	7	7	5	0.714285714285714	7	7	5	0.714285714285714	0.0394477317554241	20	20	7	0	0.609444374571327	1
"206"	"Apoptotic factor-mediated response"	7	7	2	0.285714285714286	7	7	5	0.714285714285714	0.0335305719921105	17	17	9	0	0.609444374571327	1
"207"	"CREB phosphorylation through the activation of Adenylate Cyclase"	7	7	2	0.285714285714286	7	7	5	0.714285714285714	0.100591715976331	51	56	24	0	0.609444374571327	1
"215"	"eNOS activation"	7	7	2	0.285714285714286	7	7	5	0.714285714285714	0.0216962524654832	11	11	4	0	0.609444374571327	1
"470"	"Scavenging by Class F Receptors"	7	7	1	0.142857142857143	7	7	5	0.714285714285714	0.106508875739645	54	57	43	0	0.609444374571327	1
"702"	"RNA Polymerase I Transcription Initiation"	47	47	3	0.0638297872340425	47	47	37	0.787234042553192	0.181459566074951	92	116	9	0	0.610783894989618	1
"101"	"Vpu mediated degradation of CD4"	52	52	20	0.384615384615385	52	52	41	0.788461538461538	0.136094674556213	69	78	8	0	0.613472017497706	1
"877"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	67	67	1	0.0149253731343284	67	67	53	0.791044776119403	0.209072978303748	106	126	6	0	0.621474431867246	1
"377"	"ZBP1(DAI) mediated induction of type I IFNs"	26	26	5	0.192307692307692	26	26	20	0.769230769230769	0.118343195266272	60	71	10	0	0.637601263345854	1
"446"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	26	26	4	0.153846153846154	26	26	20	0.769230769230769	0.0769230769230769	39	44	9	0	0.637601263345854	1
"172"	"G-protein beta:gamma signalling"	51	51	16	0.313725490196078	51	51	40	0.784313725490196	0.36094674556213	183	244	85	0	0.639531155434717	1
"866"	"Cargo trafficking to the periciliary membrane"	51	51	1	0.0196078431372549	51	51	40	0.784313725490196	0.238658777120316	121	165	14	0	0.639531155434717	1
"379"	"RIP-mediated NFkB activation via ZBP1"	21	21	4	0.19047619047619	21	21	16	0.761904761904762	0.0946745562130177	48	54	9	0	0.640080501914457	1
"626"	"Aflatoxin activation and detoxification"	21	21	2	0.0952380952380952	21	21	16	0.761904761904762	0.0611439842209073	31	34	4	0	0.640080501914457	1
"627"	"Defective ACY1 causes encephalopathy"	21	21	2	0.0952380952380952	21	21	16	0.761904761904762	0.0611439842209073	31	34	4	0	0.640080501914457	1
"629"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	21	21	2	0.0952380952380952	21	21	16	0.761904761904762	0.0986193293885602	50	56	8	0	0.640080501914457	1
"128"	"SCF(Skp2)-mediated degradation of p27/p21"	56	56	20	0.357142857142857	56	56	44	0.785714285714286	0.161735700197239	82	95	8	0	0.640987355543489	1
"150"	"Cyclin A:Cdk2-associated events at S phase entry"	66	66	22	0.333333333333333	66	66	52	0.787878787878788	0.201183431952663	102	121	10	0	0.644266178432983	1
"705"	"Mismatch Repair"	16	16	1	0.0625	16	16	12	0.75	0.0670611439842209	34	39	5	0	0.645382288788937	1
"703"	"G alpha (q) signalling events"	189	189	12	0.0634920634920635	189	189	151	0.798941798941799	0.650887573964497	330	693	85	0	0.648197919149443	1
"240"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	11	11	3	0.272727272727273	11	11	8	0.727272727272727	0.0591715976331361	30	38	8	0	0.65663424685144	1
"386"	"Hormone ligand-binding receptors"	11	11	2	0.181818181818182	11	11	8	0.727272727272727	0.0552268244575937	28	31	11	0	0.65663424685144	1
"639"	"Heme biosynthesis"	11	11	1	0.0909090909090909	11	11	8	0.727272727272727	0.0315581854043393	16	16	4	0	0.65663424685144	1
"24"	"Activation of CaMK IV"	2	2	1	0.5	2	2	1	0.5	0.0019723865877712	1	1	1	0	0.659032026535895	1
"27"	"Enzymatic degradation of Dopamine by monoamine oxidase"	2	2	1	0.5	2	2	1	0.5	0.0019723865877712	1	1	1	0	0.659032026535895	1
"28"	"Enzymatic degradation of dopamine by COMT"	2	2	1	0.5	2	2	1	0.5	0.0019723865877712	1	1	1	0	0.659032026535895	1
"29"	"Estrogen biosynthesis"	2	2	1	0.5	2	2	1	0.5	0.00394477317554241	2	2	2	0	0.659032026535895	1
"30"	"Inhibition of PKR"	2	2	1	0.5	2	2	1	0.5	0.0019723865877712	1	1	1	0	0.659032026535895	1
"33"	"Mitotic Metaphase/Anaphase Transition"	2	2	1	0.5	2	2	1	0.5	0.00394477317554241	2	2	2	0	0.659032026535895	1
"37"	"Resolution of D-loop structures"	2	2	1	0.5	2	2	1	0.5	0.00591715976331361	3	3	3	0	0.659032026535895	1
"38"	"Resolution of D-loop structures through Holliday junction intermediates"	2	2	1	0.5	2	2	1	0.5	0.00591715976331361	3	3	3	0	0.659032026535895	1
"103"	"Regulation of ornithine decarboxylase (ODC)"	50	50	19	0.38	50	50	39	0.78	0.132149901380671	67	76	8	0	0.665330868367179	1
"130"	"Cyclin E associated events during G1/S transition"	65	65	23	0.353846153846154	65	65	51	0.784615384615385	0.195266272189349	99	116	10	0	0.666805350456324	1
"562"	"Regulation of HSF1-mediated heat shock response"	35	35	4	0.114285714285714	35	35	27	0.771428571428571	0.173570019723866	88	105	20	0	0.667577902087396	1
"691"	"HSF1 activation"	30	30	2	0.0666666666666667	30	30	23	0.766666666666667	0.136094674556213	69	79	8	0	0.670047943869638	1
"743"	"Dual incision reaction in GG-NER"	20	20	1	0.05	20	20	15	0.75	0.0867850098619329	44	50	9	0	0.680821496729301	1
"745"	"Formation of incision complex in GG-NER"	20	20	1	0.05	20	20	15	0.75	0.0867850098619329	44	50	9	0	0.680821496729301	1
"151"	"DNA replication initiation"	6	6	2	0.333333333333333	6	6	4	0.666666666666667	0.0276134122287968	14	14	9	0	0.684397241414989	1
"160"	"Telomere C-strand synthesis initiation"	6	6	2	0.333333333333333	6	6	4	0.666666666666667	0.0276134122287968	14	14	9	0	0.684397241414989	1
"410"	"Heme degradation"	6	6	1	0.166666666666667	6	6	4	0.666666666666667	0.0138067061143984	7	7	3	0	0.684397241414989	1
"418"	"Pyrimidine biosynthesis"	6	6	1	0.166666666666667	6	6	4	0.666666666666667	0.0216962524654832	11	11	6	0	0.684397241414989	1
"264"	"Mitotic G1-G1/S phases"	135	135	36	0.266666666666667	135	135	107	0.792592592592593	0.467455621301775	237	343	71	0	0.685397820084585	1
"138"	"Vif-mediated degradation of APOBEC3G"	54	54	19	0.351851851851852	54	54	42	0.777777777777778	0.138067061143984	70	84	8	0	0.689763038014315	1
"725"	"Meiotic recombination"	54	54	3	0.0555555555555556	54	54	42	0.777777777777778	0.303747534516765	154	198	30	0	0.689763038014315	1
"870"	"Golgi Associated Vesicle Biogenesis"	54	54	1	0.0185185185185185	54	54	42	0.777777777777778	0.209072978303748	106	141	11	0	0.689763038014315	1
"715"	"Response to elevated platelet cytosolic Ca2+"	84	84	5	0.0595238095238095	84	84	66	0.785714285714286	0.579881656804734	294	537	187	0	0.690401916311509	1
"679"	"Interferon Signaling"	196	196	15	0.076530612244898	196	196	156	0.795918367346939	0.506903353057199	257	525	15	0	0.690858505516817	1
"147"	"Activation of BAD and translocation to mitochondria"	15	15	5	0.333333333333333	15	15	11	0.733333333333333	0.0532544378698225	27	27	7	0	0.692178411626114	1
"690"	"HDL-mediated lipid transport"	15	15	1	0.0666666666666667	15	15	11	0.733333333333333	0.126232741617357	64	73	33	0	0.692178411626114	1
"692"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	15	15	1	0.0666666666666667	15	15	11	0.733333333333333	0.0650887573964497	33	37	5	0	0.692178411626114	1
"693"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	15	15	1	0.0666666666666667	15	15	11	0.733333333333333	0.0591715976331361	30	35	5	0	0.692178411626114	1
"694"	"NRIF signals cell death from the nucleus"	15	15	1	0.0666666666666667	15	15	11	0.733333333333333	0.0374753451676529	19	21	5	0	0.692178411626114	1
"411"	"IKK complex recruitment mediated by RIP1"	24	24	4	0.166666666666667	24	24	18	0.75	0.100591715976331	51	61	16	0	0.710116175348953	1
"424"	"TRAF6 mediated NF-kB activation"	24	24	4	0.166666666666667	24	24	18	0.75	0.112426035502959	57	66	9	0	0.710116175348953	1
"522"	"DARPP-32 events"	24	24	3	0.125	24	24	18	0.75	0.0907297830374754	46	52	5	0	0.710116175348953	1
"873"	"DNA Damage/Telomere Stress Induced Senescence"	58	58	1	0.0172413793103448	58	58	45	0.775862068965517	0.631163708086785	320	435	257	0	0.711919794114485	1
"23"	"Abacavir transport and metabolism"	10	10	5	0.5	10	10	7	0.7	0.0591715976331361	30	31	15	0	0.713241279107033	1
"87"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	10	10	4	0.4	10	10	7	0.7	0.0276134122287968	14	14	4	0	0.713241279107033	1
"618"	"MASTL Facilitates Mitotic Progression"	10	10	1	0.1	10	10	7	0.7	0.0355029585798817	18	18	5	0	0.713241279107033	1
"154"	"G beta:gamma signalling through PI3Kgamma"	48	48	16	0.333333333333333	48	48	37	0.770833333333333	0.325443786982249	165	212	85	0	0.71566078233103	1
"585"	"Cyclin D associated events in G1"	38	38	4	0.105263157894737	38	38	29	0.763157894736842	0.270216962524655	137	157	71	0	0.722502337438134	1
"586"	"G1 Phase"	38	38	4	0.105263157894737	38	38	29	0.763157894736842	0.270216962524655	137	157	71	0	0.722502337438134	1
"293"	"Synthesis of DNA"	97	97	23	0.237113402061856	97	97	76	0.783505154639175	0.293885601577909	149	192	10	0	0.727238513974532	1
"714"	"Negative regulators of RIG-I/MDA5 signaling"	33	33	2	0.0606060606060606	33	33	25	0.757575757575758	0.143984220907298	73	88	9	0	0.727799674755255	1
"499"	"Signaling by NOTCH"	122	122	17	0.139344262295082	122	122	96	0.786885245901639	0.777120315581854	394	796	257	0	0.728617038456699	1
"65"	"Uptake and function of anthrax toxins"	14	14	6	0.428571428571429	14	14	10	0.714285714285714	0.0355029585798817	18	20	5	0	0.738284397593506	1
"210"	"Golgi Cisternae Pericentriolar Stack Reorganization"	14	14	4	0.285714285714286	14	14	10	0.714285714285714	0.0512820512820513	26	28	8	0	0.738284397593506	1
"463"	"Leading Strand Synthesis"	14	14	2	0.142857142857143	14	14	10	0.714285714285714	0.0433925049309665	22	22	4	0	0.738284397593506	1
"465"	"Polymerase switching"	14	14	2	0.142857142857143	14	14	10	0.714285714285714	0.0433925049309665	22	22	4	0	0.738284397593506	1
"466"	"Polymerase switching on the C-strand of the telomere"	14	14	2	0.142857142857143	14	14	10	0.714285714285714	0.0433925049309665	22	22	4	0	0.738284397593506	1
"469"	"Removal of the Flap Intermediate"	14	14	2	0.142857142857143	14	14	10	0.714285714285714	0.0473372781065089	24	24	5	0	0.738284397593506	1
"632"	"DNA strand elongation"	32	32	3	0.09375	32	32	24	0.75	0.124260355029586	63	67	6	0	0.756688252549925	1
"320"	"DNA Replication"	105	105	23	0.219047619047619	105	105	82	0.780952380952381	0.305719921104536	155	205	10	0	0.758800559882022	1
"79"	"Activation of caspases through apoptosome-mediated cleavage"	5	5	2	0.4	5	5	3	0.6	0.0256410256410256	13	13	9	0	0.761325525709787	1
"81"	"Cytochrome c-mediated apoptotic response"	5	5	2	0.4	5	5	3	0.6	0.0256410256410256	13	13	9	0	0.761325525709787	1
"582"	"G alpha (z) signalling events"	46	46	5	0.108695652173913	46	46	35	0.760869565217391	0.268244575936884	136	188	25	0	0.763489433692694	1
"649"	"Opioid Signalling"	80	80	7	0.0875	80	80	62	0.775	0.420118343195266	213	334	25	0	0.763628477404415	1
"747"	"Condensation of Prophase Chromosomes"	41	41	2	0.0487804878048781	41	41	31	0.75609756097561	0.175542406311637	89	96	10	0	0.76890837676199	1
"309"	"Formyl peptide receptors bind formyl peptides and many other ligands"	9	9	2	0.222222222222222	9	9	6	0.666666666666667	0.0394477317554241	20	22	7	0	0.769014025431516	1
"337"	"Fcgamma receptor (FCGR) dependent phagocytosis"	119	119	25	0.210084033613445	119	119	93	0.781512605042017	0.571992110453649	290	514	85	0	0.771968007173171	1
"233"	"G1/S Transition"	109	109	30	0.275229357798165	109	109	85	0.779816513761468	0.317554240631164	161	211	10	0	0.773075714196437	1
"722"	"Integration of energy metabolism"	104	104	6	0.0576923076923077	104	104	81	0.778846153846154	0.526627218934911	267	455	25	0	0.773842190264695	1
"236"	"Cyclin A/B1 associated events during G2/M transition"	22	22	6	0.272727272727273	22	22	16	0.727272727272727	0.0729783037475345	37	40	7	0	0.779016395375152	1
"741"	"Platelet degranulation"	79	79	4	0.0506329113924051	79	79	61	0.772151898734177	0.566074950690335	287	502	187	0	0.780708876761494	1
"664"	"Arachidonic acid metabolism"	50	50	4	0.08	50	50	38	0.76	0.222879684418146	113	133	8	0	0.780864936381232	1
"782"	"Nucleotide Excision Repair"	50	50	2	0.04	50	50	38	0.76	0.201183431952663	102	126	10	0	0.780864936381232	1
"16"	"AKT phosphorylates targets in the cytosol"	13	13	7	0.538461538461538	13	13	9	0.692307692307692	0.0571992110453649	29	32	7	0	0.782897889292892	1
"52"	"p38MAPK events"	13	13	6	0.461538461538462	13	13	9	0.692307692307692	0.0848126232741617	43	45	28	0	0.782897889292892	1
"300"	"Purine salvage"	13	13	3	0.230769230769231	13	13	9	0.692307692307692	0.029585798816568	15	16	3	0	0.782897889292892	1
"677"	"Trafficking and processing of endosomal TLR"	13	13	1	0.0769230769230769	13	13	9	0.692307692307692	0.0532544378698225	27	31	7	0	0.782897889292892	1
"402"	"Cellular Senescence"	158	158	27	0.170886075949367	158	158	124	0.784810126582278	0.775147928994083	393	775	257	0	0.783240019045635	1
"701"	"Gluconeogenesis"	31	31	2	0.0645161290322581	31	31	23	0.741935483870968	0.0966469428007889	49	58	11	0	0.78448007906985	1
"169"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	69	69	22	0.318840579710145	69	69	53	0.768115942028985	0.183431952662722	93	112	8	0	0.78553646952534	1
"835"	"PRC2 methylates histones and DNA"	40	40	1	0.025	40	40	30	0.75	0.173570019723866	88	103	9	0	0.792693455457714	1
"683"	"Protein folding"	54	54	4	0.0740740740740741	54	54	41	0.759259259259259	0.216962524654832	110	141	25	0	0.796573955210643	1
"134"	"G1/S-Specific Transcription"	17	17	6	0.352941176470588	17	17	12	0.705882352941177	0.0493096646942801	25	28	7	0	0.797366754975287	1
"295"	"Metabolism of nitric oxide"	17	17	4	0.235294117647059	17	17	12	0.705882352941177	0.0591715976331361	30	32	10	0	0.797366754975287	1
"297"	"eNOS activation and regulation"	17	17	4	0.235294117647059	17	17	12	0.705882352941177	0.0591715976331361	30	32	10	0	0.797366754975287	1
"552"	"Metabolism of porphyrins"	17	17	2	0.117647058823529	17	17	12	0.705882352941177	0.0433925049309665	22	23	4	0	0.797366754975287	1
"814"	"Diseases associated with visual transduction"	92	92	3	0.0326086956521739	92	92	71	0.771739130434783	0.41025641025641	208	343	43	0	0.805965042059941	1
"815"	"Visual phototransduction"	92	92	3	0.0326086956521739	92	92	71	0.771739130434783	0.41025641025641	208	343	43	0	0.805965042059941	1
"535"	"M Phase"	266	266	33	0.12406015037594	266	266	210	0.789473684210526	0.631163708086785	320	694	23	0	0.808731399607736	1
"783"	"G alpha (s) signalling events"	126	126	5	0.0396825396825397	126	126	98	0.777777777777778	0.469428007889546	238	404	25	0	0.809712750876529	1
"809"	"Lipoprotein metabolism"	30	30	1	0.0333333333333333	30	30	22	0.733333333333333	0.250493096646943	127	170	43	0	0.810974492744689	1
"812"	"Tight junction interactions"	30	30	1	0.0333333333333333	30	30	22	0.733333333333333	0.100591715976331	51	56	9	0	0.810974492744689	1
"462"	"Lagging Strand Synthesis"	21	21	3	0.142857142857143	21	21	15	0.714285714285714	0.0670611439842209	34	35	5	0	0.811192680136805	1
"749"	"APC/C:Cdc20 mediated degradation of Cyclin B"	21	21	1	0.0476190476190476	21	21	15	0.714285714285714	0.0631163708086785	32	36	7	0	0.811192680136805	1
"756"	"Inflammasomes"	21	21	1	0.0476190476190476	21	21	15	0.714285714285714	0.0986193293885602	50	56	14	0	0.811192680136805	1
"652"	"Mitotic Prophase"	106	106	9	0.0849056603773585	106	106	82	0.773584905660377	0.388560157790927	197	284	11	0	0.814576456111756	1
"40"	"VEGF binds to VEGFR leading to receptor dimerization"	8	8	4	0.5	8	8	5	0.625	0.0650887573964497	33	36	12	0	0.8224367486752	1
"41"	"VEGF ligand-receptor interactions"	8	8	4	0.5	8	8	5	0.625	0.0650887573964497	33	36	12	0	0.8224367486752	1
"106"	"Erythrocytes take up carbon dioxide and release oxygen"	8	8	3	0.375	8	8	5	0.625	0.0236686390532544	12	12	5	0	0.8224367486752	1
"107"	"Erythrocytes take up oxygen and release carbon dioxide"	8	8	3	0.375	8	8	5	0.625	0.0236686390532544	12	12	5	0	0.8224367486752	1
"111"	"O2/CO2 exchange in erythrocytes"	8	8	3	0.375	8	8	5	0.625	0.0236686390532544	12	12	5	0	0.8224367486752	1
"222"	"Activation of BH3-only proteins"	25	25	7	0.28	25	25	18	0.72	0.538461538461538	273	292	257	0	0.824077417608468	1
"658"	"Processive synthesis on the C-strand of the telomere"	12	12	1	0.0833333333333333	12	12	8	0.666666666666667	0.0414201183431953	21	22	5	0	0.825160265846142	1
"836"	"Unfolded Protein Response (UPR)"	81	81	2	0.0246913580246914	81	81	62	0.765432098765432	0.252465483234714	128	177	19	0	0.825285705590213	1
"454"	"Regulation of actin dynamics for phagocytic cup formation"	95	95	14	0.147368421052632	95	95	73	0.768421052631579	0.42603550295858	216	319	21	0	0.831492143951739	1
"382"	"Processive synthesis on the lagging strand"	16	16	3	0.1875	16	16	11	0.6875	0.0512820512820513	26	27	5	0	0.832566780137644	1
"837"	"Transcription"	203	203	5	0.0246305418719212	203	203	159	0.783251231527094	0.495069033530572	251	482	20	0	0.833026754663098	1
"502"	"Extension of Telomeres"	29	29	4	0.137931034482759	29	29	21	0.724137931034483	0.0986193293885602	50	54	9	0	0.835985740014392	1
"801"	"RNA Polymerase I Promoter Escape"	29	29	1	0.0344827586206897	29	29	21	0.724137931034483	0.0907297830374754	46	52	9	0	0.835985740014392	1
"25"	"Activation of PKB"	4	4	2	0.5	4	4	2	0.5	0.00788954635108481	4	4	3	0	0.837120757755282	1
"26"	"CREB phosphorylation through the activation of CaMKK"	4	4	2	0.5	4	4	2	0.5	0.00394477317554241	2	2	1	0	0.837120757755282	1
"277"	"NS1 Mediated Effects on Host Pathways"	4	4	1	0.25	4	4	2	0.5	0.00591715976331361	3	3	2	0	0.837120757755282	1
"874"	"Clathrin derived vesicle budding"	61	61	1	0.0163934426229508	61	61	46	0.754098360655738	0.22879684418146	116	159	11	0	0.840294556026855	1
"875"	"trans-Golgi Network Vesicle Budding"	61	61	1	0.0163934426229508	61	61	46	0.754098360655738	0.22879684418146	116	159	11	0	0.840294556026855	1
"876"	"Late Phase of HIV Life Cycle"	133	133	2	0.0150375939849624	133	133	103	0.774436090225564	0.388560157790927	197	333	20	0	0.841734739231781	1
"185"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	70	70	21	0.3	70	70	53	0.757142857142857	0.187376725838264	95	116	8	0	0.846714054465253	1
"849"	"Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"850"	"Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"851"	"Defective GGT1 causes Glutathionuria (GLUTH)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"852"	"Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"853"	"Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"854"	"Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"855"	"Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"856"	"Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"857"	"Defective UGT1A1 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"858"	"Defective UGT1A4 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"859"	"Phase II conjugation"	89	89	2	0.0224719101123595	89	89	68	0.764044943820225	0.272189349112426	138	203	12	0	0.846964087874354	1
"713"	"Glucagon signaling in metabolic regulation"	33	33	2	0.0606060606060606	33	33	24	0.727272727272727	0.222879684418146	113	137	25	0	0.846965058158271	1
"170"	"Autodegradation of Cdh1 by Cdh1:APC/C"	60	60	19	0.316666666666667	60	60	45	0.75	0.157790927021696	80	91	7	0	0.855881866202508	1
"697"	"Telomere Maintenance"	60	60	4	0.0666666666666667	60	60	45	0.75	0.209072978303748	106	122	9	0	0.855881866202508	1
"803"	"HIV Life Cycle"	146	146	5	0.0342465753424658	146	146	113	0.773972602739726	0.414201183431953	210	365	20	0	0.858179415749423	1
"203"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	69	69	20	0.289855072463768	69	69	52	0.753623188405797	0.183431952662722	93	114	8	0	0.860858009303201	1
"190"	"APC/C:Cdc20 mediated degradation of Securin"	64	64	19	0.296875	64	64	48	0.75	0.167652859960552	85	100	8	0	0.865436057637436	1
"824"	"DNA methylation"	32	32	1	0.03125	32	32	23	0.71875	0.136094674556213	69	75	9	0	0.867855558629624	1
"653"	"Organelle biogenesis and maintenance"	323	323	27	0.0835913312693498	323	323	254	0.786377708978328	0.727810650887574	369	1024	29	0	0.868567588147283	1
"181"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	73	73	22	0.301369863013699	73	73	55	0.753424657534247	0.189349112426035	96	119	8	0	0.869931183282622	1
"3"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	7	7	5	0.714285714285714	7	7	4	0.571428571428571	0.0157790927021696	8	8	3	0	0.871779408524142	1
"515"	"Telomere C-strand (Lagging Strand) Synthesis"	23	23	3	0.130434782608696	23	23	16	0.695652173913043	0.0828402366863905	42	44	9	0	0.874823549138888	1
"774"	"APC-Cdc20 mediated degradation of Nek2A"	23	23	1	0.0434782608695652	23	23	16	0.695652173913043	0.0670611439842209	34	40	7	0	0.874823549138888	1
"773"	"Transcription-coupled NER (TC-NER)"	45	45	2	0.0444444444444444	45	45	33	0.733333333333333	0.179487179487179	91	109	10	0	0.875056964249246	1
"711"	"Metabolic disorders of biological oxidation enzymes"	614	614	38	0.0618892508143322	614	614	487	0.793159609120521	0.848126232741617	430	1554	24	0	0.880300886093697	1
"200"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	72	72	21	0.291666666666667	72	72	54	0.75	0.187376725838264	95	117	8	0	0.882348286793116	1
"168"	"Interleukin-1 signaling"	40	40	13	0.325	40	40	29	0.725	0.173570019723866	88	105	9	0	0.883482238973638	1
"681"	"Interferon alpha/beta signaling"	67	67	5	0.0746268656716418	67	67	50	0.746268656716418	0.238658777120316	121	158	13	0	0.886820774448992	1
"230"	"Synthesis and interconversion of nucleotide di- and triphosphates"	18	18	5	0.277777777777778	18	18	12	0.666666666666667	0.0611439842209073	31	32	13	0	0.894553774802986	1
"310"	"Post-chaperonin tubulin folding pathway"	18	18	4	0.222222222222222	18	18	12	0.666666666666667	0.0571992110453649	29	33	9	0	0.894553774802986	1
"777"	"Epigenetic regulation of gene expression"	94	94	4	0.0425531914893617	94	94	71	0.75531914893617	0.323471400394477	164	230	9	0	0.896824802588601	1
"764"	"Vasopressin regulates renal water homeostasis via Aquaporins"	43	43	2	0.0465116279069767	43	43	31	0.720930232558139	0.242603550295858	123	155	25	0	0.904925435700493	1
"7"	"Formation of apoptosome"	3	3	2	0.666666666666667	3	3	1	0.333333333333333	0.0177514792899408	9	9	9	0	0.907130070868191	1
"149"	"CaMK IV-mediated phosphorylation of CREB"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0019723865877712	1	1	1	0	0.907130070868191	1
"159"	"TNF signaling"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00986193293885602	5	5	5	0	0.907130070868191	1
"536"	"HIV Infection"	227	227	28	0.123348017621145	227	227	176	0.775330396475771	0.542406311637081	275	550	20	0	0.908225417683139	1
"718"	"Global Genomic NER (GG-NER)"	34	34	2	0.0588235294117647	34	34	24	0.705882352941177	0.132149901380671	67	79	9	0	0.909177397479842	1
"848"	"Glycerophospholipid biosynthesis"	88	88	2	0.0227272727272727	88	88	66	0.75	0.272189349112426	138	186	11	0	0.909250891639157	1
"739"	"G alpha (i) signalling events"	236	236	12	0.0508474576271186	236	236	183	0.775423728813559	0.58974358974359	299	660	25	0	0.912426752409678	1
"183"	"APC/C-mediated degradation of cell cycle proteins"	83	83	25	0.301204819277108	83	83	62	0.746987951807229	0.218934911242604	111	140	8	0	0.912647081559057	1
"184"	"Regulation of mitotic cell cycle"	83	83	25	0.301204819277108	83	83	62	0.746987951807229	0.218934911242604	111	140	8	0	0.912647081559057	1
"294"	"Intrinsic Pathway for Apoptosis"	38	38	9	0.236842105263158	38	38	27	0.710526315789474	0.593688362919132	301	359	257	0	0.913645008172294	1
"661"	"Class I MHC mediated antigen processing & presentation"	255	255	21	0.0823529411764706	255	255	198	0.776470588235294	0.654832347140039	332	742	38	0	0.915356343061507	1
"784"	"Aquaporin-mediated transport"	51	51	2	0.0392156862745098	51	51	37	0.725490196078431	0.264299802761341	134	170	25	0	0.915484683430601	1
"555"	"Phosphorylation of the APC/C"	17	17	2	0.117647058823529	17	17	11	0.647058823529412	0.0512820512820513	26	28	7	0	0.917046840527301	1
"716"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	17	17	1	0.0588235294117647	17	17	11	0.647058823529412	0.0650887573964497	33	35	9	0	0.917046840527301	1
"717"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	17	17	1	0.0588235294117647	17	17	11	0.647058823529412	0.0650887573964497	33	35	9	0	0.917046840527301	1
"766"	"Chromosome Maintenance"	87	87	4	0.0459770114942529	87	87	65	0.747126436781609	0.272189349112426	138	169	9	0	0.918003460520408	1
"798"	"Class B/2 (Secretin family receptors)"	87	87	3	0.0344827586206897	87	87	65	0.747126436781609	0.240631163708087	122	168	11	0	0.918003460520408	1
"754"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	42	42	2	0.0476190476190476	42	42	30	0.714285714285714	0.222879684418146	113	145	24	0	0.918061132510343	1
"447"	"Resolution of AP sites via the single-nucleotide replacement pathway"	13	13	2	0.153846153846154	13	13	8	0.615384615384615	0.0374753451676529	19	20	6	0	0.920250613090954	1
"188"	"FCERI mediated MAPK activation"	77	77	23	0.298701298701299	77	77	57	0.74025974025974	0.291913214990138	148	201	28	0	0.925094369673813	1
"212"	"Regulation of APC/C activators between G1/S and early anaphase"	77	77	22	0.285714285714286	77	77	57	0.74025974025974	0.205128205128205	104	129	8	0	0.925094369673813	1
"785"	"Regulation of insulin secretion"	77	77	3	0.038961038961039	77	77	57	0.74025974025974	0.406311637080868	206	315	24	0	0.925094369673813	1
"429"	"Cellular responses to stress"	248	248	40	0.161290322580645	248	248	192	0.774193548387097	0.848126232741617	430	1050	257	0	0.925431213403332	1
"60"	"Pyrimidine salvage reactions"	9	9	4	0.444444444444444	9	9	5	0.555555555555556	0.029585798816568	15	15	4	0	0.929282195162567	1
"733"	"RNA Polymerase I Promoter Clearance"	76	76	4	0.0526315789473684	76	76	56	0.736842105263158	0.2465483234714	125	164	9	0	0.933229979386899	1
"341"	"Pyrimidine metabolism"	24	24	5	0.208333333333333	24	24	16	0.666666666666667	0.104536489151874	53	57	15	0	0.933992418135608	1
"449"	"Base Excision Repair"	20	20	3	0.15	20	20	13	0.65	0.0611439842209073	31	34	6	0	0.934310531349705	1
"450"	"Resolution of Abasic Sites (AP sites)"	20	20	3	0.15	20	20	13	0.65	0.0611439842209073	31	34	6	0	0.934310531349705	1
"687"	"Class A/1 (Rhodopsin-like receptors)"	314	314	22	0.0700636942675159	314	314	244	0.777070063694268	0.644970414201183	327	743	14	0	0.935489915788692	1
"630"	"Antigen processing: Ubiquitination & Proteasome degradation"	211	211	20	0.0947867298578199	211	211	162	0.767772511848341	0.599605522682446	304	597	38	0	0.939205147063127	1
"280"	"Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis"	12	12	3	0.25	12	12	7	0.583333333333333	0.0355029585798817	18	21	7	0	0.942259563673558	1
"682"	"Detoxification of Reactive Oxygen Species"	27	27	2	0.0740740740740741	27	27	18	0.666666666666667	0.0690335305719921	35	37	10	0	0.947328045319809	1
"820"	"RNA Polymerase I Transcription Termination"	31	31	1	0.032258064516129	31	31	21	0.67741935483871	0.0927021696252465	47	53	9	0	0.947839584985738	1
"357"	"G2 Phase"	5	5	1	0.2	5	5	2	0.4	0.0177514792899408	9	9	7	0	0.950813605823525	1
"797"	"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription"	114	114	4	0.0350877192982456	114	114	85	0.745614035087719	0.317554240631164	161	259	14	0	0.951820350295085	1
"278"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	8	8	2	0.25	8	8	4	0.5	0.00986193293885602	5	5	2	0	0.954017174939046	1
"331"	"Role of LAT2/NTAL/LAB on calcium mobilization"	141	141	30	0.212765957446809	141	141	106	0.75177304964539	0.548323471400395	278	494	85	0	0.955002366893619	1
"164"	"TCR signaling"	64	64	21	0.328125	64	64	46	0.71875	0.366863905325444	186	253	85	0	0.955288318598753	1
"807"	"Gap junction trafficking and regulation"	30	30	1	0.0333333333333333	30	30	20	0.666666666666667	0.132149901380671	67	80	10	0	0.957795051405559	1
"811"	"RNA Polymerase I Promoter Opening"	30	30	1	0.0333333333333333	30	30	20	0.666666666666667	0.100591715976331	51	53	6	0	0.957795051405559	1
"635"	"Base-free sugar-phosphate removal via the single-nucleotide replacement pathway"	11	11	1	0.0909090909090909	11	11	6	0.545454545454545	0.0236686390532544	12	12	3	0	0.960325303222023	1
"577"	"Removal of DNA patch containing abasic residue"	18	18	2	0.111111111111111	18	18	11	0.611111111111111	0.0493096646942801	25	26	4	0	0.96203297197593	1
"578"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	18	18	2	0.111111111111111	18	18	11	0.611111111111111	0.0493096646942801	25	26	4	0	0.96203297197593	1
"665"	"Lipid digestion, mobilization, and transport"	50	50	4	0.08	50	50	35	0.7	0.305719921104536	155	225	43	0	0.962379840901889	1
"678"	"Metabolism"	1565	1565	120	0.0766773162939297	1565	1565	1245	0.795527156549521	0.976331360946746	495	4455	85	0	0.964358483092292	1
"433"	"Regulation of IFNA signaling"	25	25	4	0.16	25	25	16	0.64	0.0749506903353057	38	42	7	0	0.967337618791442	1
"645"	"RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"	79	79	7	0.0886075949367089	79	79	57	0.721518987341772	0.386587771203156	196	288	42	0	0.968267417777948	1
"796"	"Pre-NOTCH Expression and Processing"	57	57	2	0.0350877192982456	57	57	40	0.701754385964912	0.710059171597633	360	544	257	0	0.970411309499154	1
"738"	"RNA Polymerase I Transcription"	78	78	4	0.0512820512820513	78	78	56	0.717948717948718	0.2465483234714	125	164	9	0	0.972352956882074	1
"723"	"Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)"	441	441	25	0.0566893424036281	441	441	342	0.775510204081633	0.765285996055227	388	1096	24	0	0.972432760684808	1
"724"	"GPCR ligand binding"	441	441	25	0.0566893424036281	441	441	342	0.775510204081633	0.765285996055227	388	1096	24	0	0.972432760684808	1
"708"	"TRAF6 mediated IRF7 activation"	32	32	2	0.0625	32	32	21	0.65625	0.205128205128205	104	124	32	0	0.972910855248308	1
"82"	"IRAK1 recruits IKK complex"	10	10	4	0.4	10	10	5	0.5	0.0414201183431953	21	21	9	0	0.974479837623457	1
"83"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	10	10	4	0.4	10	10	5	0.5	0.0414201183431953	21	21	9	0	0.974479837623457	1
"384"	"Host Interactions of HIV factors"	135	135	25	0.185185185185185	135	135	100	0.740740740740741	0.398422090729783	202	329	13	0	0.975185555422511	1
"736"	"Negative epigenetic regulation of rRNA expression"	77	77	4	0.051948051948052	77	77	55	0.714285714285714	0.244575936883629	124	162	9	0	0.976026215244221	1
"573"	"FCERI mediated Ca+2 mobilization"	62	62	7	0.112903225806452	62	62	43	0.693548387096774	0.236686390532544	120	160	18	0	0.983313790875911	1
"731"	"NoRC negatively regulates rRNA expression"	74	74	4	0.0540540540540541	74	74	52	0.702702702702703	0.240631163708087	122	155	9	0	0.984830970032253	1
"748"	"Pre-NOTCH Transcription and Translation"	41	41	2	0.0487804878048781	41	41	27	0.658536585365854	0.696252465483235	353	505	257	0	0.985642279016396	1
"182"	"Costimulation by the CD28 family"	73	73	22	0.301369863013699	73	73	51	0.698630136986301	0.351084812623274	178	233	85	0	0.987114620046726	1
"872"	"RNA Polymerase I Chain Elongation"	56	56	1	0.0178571428571429	56	56	38	0.678571428571429	0.167652859960552	85	97	9	0	0.988245376407822	1
"663"	"ADP signalling through P2Y purinoceptor 1"	25	25	2	0.08	25	25	15	0.6	0.0532544378698225	27	28	4	0	0.988743881282915	1
"534"	"Thrombin signalling through proteinase activated receptors (PARs)"	32	32	4	0.125	32	32	20	0.625	0.0769230769230769	39	42	8	0	0.989756457106858	1
"633"	"Signal amplification"	32	32	3	0.09375	32	32	20	0.625	0.0690335305719921	35	37	4	0	0.989756457106858	1
"395"	"Innate Immune System"	618	618	107	0.173139158576052	618	618	479	0.775080906148867	0.915187376725838	464	2146	85	0	0.990460326675306	1
"434"	"Senescence-Associated Secretory Phenotype (SASP)"	75	75	12	0.16	75	75	52	0.693333333333333	0.341222879684418	173	230	71	0	0.991075067563015	1
"686"	"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"	14	14	1	0.0714285714285714	14	14	7	0.5	0.0493096646942801	25	25	7	0	0.99180599303972	1
"519"	"Adaptive Immune System"	654	654	82	0.125382262996942	654	654	507	0.775229357798165	0.903353057199211	458	2060	85	0	0.992031982880139	1
"166"	"Downstream TCR signaling"	46	46	15	0.326086956521739	46	46	30	0.652173913043478	0.309664694280079	157	191	85	0	0.992458050858407	1
"298"	"Metabolism of nucleotides"	78	78	18	0.230769230769231	78	78	54	0.692307692307692	0.256410256410256	130	167	15	0	0.992678710770898	1
"762"	"Peptide ligand-binding receptors"	190	190	9	0.0473684210526316	190	190	140	0.736842105263158	0.499013806706114	253	443	14	0	0.993709048767933	1
"518"	"Immune System"	1216	1216	153	0.125822368421053	1216	1216	955	0.785361842105263	0.962524654832347	488	3898	85	0	0.993893822920411	1
"808"	"Glucagon-type ligand receptors"	30	30	1	0.0333333333333333	30	30	18	0.6	0.0710059171597633	36	43	7	0	0.99433298251021	1
"613"	"Alpha-defensins"	10	10	1	0.1	10	10	4	0.4	0.0177514792899408	9	9	6	0	0.995391961695829	1
"767"	"ADP signalling through P2Y purinoceptor 12"	22	22	1	0.0454545454545455	22	22	12	0.545454545454545	0.0433925049309665	22	23	4	0	0.996163344851889	1
"430"	"Role of phospholipids in phagocytosis"	62	62	10	0.161290322580645	62	62	41	0.661290322580645	0.366863905325444	186	250	85	0	0.996572984831636	1
"689"	"Complement cascade"	75	75	5	0.0666666666666667	75	75	50	0.666666666666667	0.291913214990138	148	211	18	0	0.998097186399234	1
"242"	"Generation of second messenger molecules"	37	37	10	0.27027027027027	37	37	22	0.594594594594595	0.106508875739645	54	59	9	0	0.998241271296192	1
"615"	"Creation of C4 and C2 activators"	50	50	5	0.1	50	50	31	0.62	0.142011834319527	72	83	8	0	0.998850001927021	1
"494"	"FCERI mediated NF-kB activation"	57	57	8	0.140350877192982	57	57	36	0.631578947368421	0.175542406311637	89	109	10	0	0.99896800595361	1
"792"	"Synthesis of PA"	28	28	1	0.0357142857142857	28	28	15	0.535714285714286	0.0887573964497041	45	50	11	0	0.999218469939508	1
"684"	"Chemokine receptors bind chemokines"	55	55	4	0.0727272727272727	55	55	34	0.618181818181818	0.100591715976331	51	62	5	0	0.99940228418171	1
"647"	"Initial triggering of complement"	57	57	5	0.087719298245614	57	57	35	0.614035087719298	0.165680473372781	84	100	12	0	0.999626334792347	1
"292"	"Phosphorylation of CD3 and TCR zeta chains"	25	25	6	0.24	25	25	12	0.48	0.0493096646942801	25	27	12	0	0.99980954775039	1
"505"	"Early Phase of HIV Life Cycle"	22	22	3	0.136363636363636	22	22	10	0.454545454545455	0.0611439842209073	31	32	7	0	0.999813030644124	1
"572"	"Classical antibody-mediated complement activation"	44	44	5	0.113636363636364	44	44	25	0.568181818181818	0.120315581854043	61	66	8	0	0.999832232171549	1
"832"	"Binding and Uptake of Ligands by Scavenger Receptors"	76	76	2	0.0263157894736842	76	76	48	0.631578947368421	0.349112426035503	177	266	43	0	0.999838884859044	1
"660"	"Disease"	1954	1954	162	0.082906857727738	1954	1954	1531	0.783520982599795	0.986193293885602	500	5821	85	0	0.9998626405613	1
"370"	"Uptake and actions of bacterial toxins"	40	40	8	0.2	40	40	22	0.55	0.120315581854043	61	69	8	0	0.999869308749328	1
"317"	"FCGR activation"	50	50	11	0.22	50	50	29	0.58	0.149901380670611	76	83	8	0	0.999874994541541	1
"830"	"Beta defensins"	36	36	1	0.0277777777777778	36	36	19	0.527777777777778	0.0611439842209073	31	34	4	0	0.999904291814022	1
"268"	"Translocation of ZAP-70 to Immunological synapse"	23	23	6	0.260869565217391	23	23	10	0.434782608695652	0.0276134122287968	14	15	3	0	0.999938964275368	1
"860"	"Scavenging of heme from plasma"	47	47	1	0.0212765957446809	47	47	26	0.553191489361702	0.159763313609467	81	98	25	0	0.999958446134133	1
"283"	"PD-1 signaling"	28	28	7	0.25	28	28	12	0.428571428571429	0.0315581854043393	16	17	3	0	0.999992999601272	1
"887"	"Mitochondrial translation"	92	92	1	0.0108695652173913	92	92	56	0.608695652173913	0.181459566074951	92	114	5	0	0.999995977895453	1
"406"	"Binding and entry of HIV virion"	12	12	2	0.166666666666667	12	12	2	0.166666666666667	0.00591715976331361	3	3	2	0	0.999997531773479	1
"883"	"Mitochondrial translation initiation"	86	86	1	0.0116279069767442	86	86	51	0.593023255813954	0.159763313609467	81	97	5	0	0.999998117060856	1
"884"	"Mitochondrial translation termination"	86	86	1	0.0116279069767442	86	86	51	0.593023255813954	0.16370808678501	83	98	5	0	0.999998117060856	1
"776"	"Defensins"	46	46	2	0.0434782608695652	46	46	23	0.5	0.0788954635108481	40	43	6	0	0.999998349533882	1
"730"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	111	111	6	0.0540540540540541	111	111	68	0.612612612612613	0.319526627218935	162	251	13	0	0.999999343649732	1
"882"	"Mitochondrial translation elongation"	86	86	1	0.0116279069767442	86	86	50	0.581395348837209	0.153846153846154	78	93	5	0	0.999999404396976	1
"869"	"Metabolism of proteins"	694	694	13	0.0187319884726225	694	694	513	0.739193083573487	0.867850098619329	440	1900	92	0	0.999999524598026	1
"864"	"Influenza Infection"	148	148	3	0.0202702702702703	148	148	85	0.574324324324324	0.297830374753452	151	227	11	0	0.999999999984623	1
"879"	"Influenza Life Cycle"	143	143	2	0.013986013986014	143	143	81	0.566433566433566	0.293885601577909	149	221	11	0	0.999999999991414	1
"878"	"Influenza Viral RNA Transcription and Replication"	135	135	2	0.0148148148148148	135	135	75	0.555555555555556	0.27810650887574	141	204	11	0	0.999999999994785	1
"894"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	106	106	1	0.00943396226415094	106	106	53	0.5	0.214990138067061	109	148	15	0	0.999999999999713	1
"895"	"Nonsense-Mediated Decay (NMD)"	106	106	1	0.00943396226415094	106	106	53	0.5	0.214990138067061	109	148	15	0	0.999999999999713	1
"921"	"Translation"	148	148	1	0.00675675675675676	148	148	81	0.547297297297297	0.256410256410256	130	173	15	0	0.999999999999901	1
"920"	"The citric acid (TCA) cycle and respiratory electron transport"	147	147	1	0.00680272108843537	147	147	80	0.54421768707483	0.236686390532544	120	156	6	0	0.999999999999934	1
"897"	"Cap-dependent Translation Initiation"	112	112	1	0.00892857142857143	112	112	55	0.491071428571429	0.179487179487179	91	116	15	0	0.999999999999987	1
"898"	"Eukaryotic Translation Initiation"	112	112	1	0.00892857142857143	112	112	55	0.491071428571429	0.179487179487179	91	116	15	0	0.999999999999987	1
"886"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	89	89	1	0.0112359550561798	89	89	38	0.426966292134831	0.134122287968442	68	83	15	0	0.999999999999999	1
"893"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	105	105	1	0.00952380952380952	105	105	48	0.457142857142857	0.161735700197239	82	99	15	0	1	1
"885"	"Eukaryotic Translation Elongation"	89	89	1	0.0112359550561798	89	89	37	0.415730337078652	0.102564102564103	52	58	8	0	1	1
"891"	"3' -UTR-mediated translational regulation"	104	104	1	0.00961538461538462	104	104	47	0.451923076923077	0.155818540433925	79	93	15	0	1	1
"892"	"L13a-mediated translational silencing of Ceruloplasmin expression"	104	104	1	0.00961538461538462	104	104	47	0.451923076923077	0.155818540433925	79	93	15	0	1	1
"880"	"Eukaryotic Translation Termination"	84	84	1	0.0119047619047619	84	84	33	0.392857142857143	0.0808678500986193	41	49	6	0	1	1
"881"	"Peptide chain elongation"	84	84	1	0.0119047619047619	84	84	33	0.392857142857143	0.0946745562130177	48	53	8	0	1	1
"888"	"Viral mRNA Translation"	92	92	1	0.0108695652173913	92	92	37	0.402173913043478	0.0986193293885602	50	58	9	0	1	1
"889"	"Formation of a pool of free 40S subunits"	94	94	1	0.0106382978723404	94	94	39	0.414893617021277	0.106508875739645	54	62	5	0	1	1
"896"	"SRP-dependent cotranslational protein targeting to membrane"	109	109	1	0.00917431192660551	109	109	49	0.44954128440367	0.120315581854043	61	73	3	0	1	1
